KR101548370B1 - Anthracene derivative and organic electroluminescent device including the same - Google Patents
Anthracene derivative and organic electroluminescent device including the same Download PDFInfo
- Publication number
- KR101548370B1 KR101548370B1 KR1020130123997A KR20130123997A KR101548370B1 KR 101548370 B1 KR101548370 B1 KR 101548370B1 KR 1020130123997 A KR1020130123997 A KR 1020130123997A KR 20130123997 A KR20130123997 A KR 20130123997A KR 101548370 B1 KR101548370 B1 KR 101548370B1
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- layer
- mmol
- synthesis
- mks
- Prior art date
Links
Images
Classifications
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/615—Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/11—OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/615—Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
- H10K85/626—Polycyclic condensed aromatic hydrocarbons, e.g. anthracene containing more than one polycyclic condensed aromatic rings, e.g. bis-anthracene
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/631—Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Optics & Photonics (AREA)
- Electroluminescent Light Sources (AREA)
Abstract
Description
본 발명은 안트라센 유도체 및 이를 포함한 유기 전계발광 소자에 관한 것으로, 특히 발광 효율이 높은 유기 전계발광 소자 및 이를 위한 신규한 안트라센 유도체에 관한 것이다. The present invention relates to an anthracene derivative and an organic electroluminescent device including the same, and more particularly to an organic electroluminescent device having a high luminous efficiency and a novel anthracene derivative for the same.
1987년 Tang과 Van Slyke가 유기전계발광소자(organic light emitting diode, OLED)의 다층 박막 구조를 이용하여 고효율의 특성을 보고한 이후 [Tang, C. W., Van Slyke, S. A. Appl. Phys. Lett. 51, 91 (1987)], OLED는 차세대 디스플레이로서의 우수한 특성 뿐만 아니라 LCD 배면광 및 조명 등에 사용가능한 높은 잠재력을 가지고 있어 각광을 받으며 많은 연구가 진행되고 있다[Kido, J., Kimura, M., and Nagai, K., Science 267, 1332 (1995)]. 특히 발광 효율을 높이기 위해 소자의 구조 변화 및 물질 개발 등 다양한 접근이 이루어지고 있다[Sun, S., Forrest, S. R., Appl. Phys. Lett. 91, 263503 (2007)/Ken-Tsung Wong, Org. Lett., 7, 2005, 5361-5364]. 발광재료 측면에서 청색 재료의 경우, 이데미쓰-고산의 청색 재료 시스템(DPVBi), 코닥의 디나프틸안트라센(9,10-di(2-naphthyl)anthracene), 테트라(t-부틸)페릴렌(tetra(t-butyl)perlyene) 시스템 등이 알려져 있으나, 아직도 고색순도의 청색을 만족시키지 못하고 수명 및 휘도가 낮은 문제점을 갖고 있어서, 많은 연구 개발이 이루어져야 할 것으로 보여진다.In 1987, Tang and Van Slyke reported the characteristics of high efficiency using a multilayer thin film structure of an organic light emitting diode (OLED) [Tang, C. W., Van Slyke, S. A. Appl. Phys. Lett. 51, 91 (1987)], OLEDs have a high potential for use in LCD backlighting and lighting as well as excellent characteristics as a next generation display, and many studies have been conducted under the spotlight [Kido, J., Kimura, M., and Nagai, K., Science 267,1332 (1995)]. Especially, in order to increase the luminous efficiency, various approaches such as structural change and material development have been performed [Sun, S., Forrest, S. R., Appl. Phys. Lett. 91, 263503 (2007) / Ken-Tsung Wong, Org. Lett., 7, 2005, 5361-5364]. In the case of the blue material in terms of the light emitting material, the blue material system (DPVBi) of Idemitsu-Gosan, the anthracene (9,10-di (2-naphthyl) anthracene of KODAK, tetra (t-butyl) perylene) system are known, but they still do not satisfy the high color purity blue, and have a problem of low lifetime and low brightness, so that much research and development is required.
이외에도 유기 발광소자에서 사용되는 물질은 수분이나 산소에 의한 물질의 변형이 적은 것이 바람직하다. 그리고, 소자의 안정성을 위해 금속 또는 금속 산화물을 포함한 전극과의 계면을 좋게 하는 것이 필요하다. 따라서 이와 같은 유기 EL 재료에 대한 연구가 지속적으로 요구되고 있다. In addition, it is preferable that the material used in the organic light emitting device is less deformed by moisture or oxygen. In addition, for the stability of the device, it is necessary to improve the interface with the electrode including the metal or the metal oxide. Therefore, research on such organic EL materials is continuously required.
본 발명의 과제는 종래의 재료보다 발광 효율이 우수하고 내구성이 뛰어난 신규한 안트라센 유도체를 제공하는 것이며, 또한 상기 안트라센 유도체가 유기물층에 포함되어 발광 효율이 개선된 유기 전계발광 소자를 제공하는 것이다.It is an object of the present invention to provide a novel anthracene derivative which is superior in luminous efficiency and durability to that of a conventional material, and that the anthracene derivative is included in the organic material layer to improve the luminous efficiency.
본 발명의 일 측면에 의하면, 하기 화학식 1로 표시되는 안트라센 유도체가 제공된다.According to an aspect of the present invention, there is provided an anthracene derivative represented by the following general formula (1).
[화학식 1][Chemical Formula 1]
[상기 화학식 1에 있어서,[In the
R1은 수소, 할로겐, 아미노, 니트로, 시아노, 히드록시, 치환 또는 비치환된 C1-C30 알킬, 치환 또는 비치환된 C3-C30 시클로알킬, 치환 또는 비치환된 C6-C30 아릴, 치환 또는 비치환된 C6-C30 아르알킬(aralkyl), 치환 또는 비치환된 C1-C30 헤테로알킬, 치환 또는 비치환된 C2-C30 헤테로시클로알킬, 치환 또는 비치환된 C5-C30 헤테로아릴, 치환 또는 비치환된 C5-C30 헤테로아르알킬이고,R 1 is hydrogen, halogen, amino, nitro, cyano, hydroxy, substituted or unsubstituted C 1 -C 30 alkyl, substituted or unsubstituted C 3 -C 30 cycloalkyl, substituted or unsubstituted C 6 - C 30 aryl group, a substituted or unsubstituted C 6 -C 30 aralkyl (aralkyl), substituted or unsubstituted C 1 -C 30 heteroalkyl, substituted or unsubstituted C 2 -C 30 heterocycloalkyl, substituted or unsubstituted Substituted C 5 -C 30 heteroaryl, substituted or unsubstituted C 5 -C 30 heteroaralkyl,
p는 1 내지 4의 정수이며,p is an integer of 1 to 4,
하나의 고리 내에 치환된 둘 이상의 R1은 서로 같거나 다르고, 인접한 R1은 각각 치환 또는 비치환된 C3-C20 알킬렌이나 치환 또는 비치환된 C3-C20 알케닐렌으로 서로 연결되어 융합고리를 형성할 수 있고,Are two or more substituted in one ring R 1 are the same or different, and adjacent R 1 are connected to each other, each substituted or unsubstituted C 3 -C 20 alkylene or a substituted or unsubstituted C 3 -C 20 alkenylene To form a fused ring,
L1 및 L2는 각각 독립적으로 화학 결합, 치환 또는 비치환된 C6-C30 아릴이거나 치환 또는 비치환된 C6-C30 헤테로아릴이며,L 1 and L 2 are each independently a chemical bond, a substituted or unsubstituted C 6 -C 30 aryl or a substituted or unsubstituted C 6 -C 30 heteroaryl,
Ar은 치환 또는 비치환된 C6-C30 아릴이거나 치환 또는 비치환된 C6-C30 헤테로아릴이다.]Ar is a substituted or unsubstituted C 6 -C 30 aryl or a substituted or unsubstituted C 6 -C 30 heteroaryl group.]
본 발명의 다른 측면에 의하면, 상술한 안트라센 유도체를 포함하는 유기 전계발광 소자가 제공된다.According to another aspect of the present invention, there is provided an organic electroluminescent device comprising the above-described anthracene derivative.
본 발명의 또 다른 측면에 의하면, 제1 전극, 제2 전극, 및 상기 전극들 사이에 배치된 1층 이상의 유기막을 포함하되, 상기 유기막은 상술한 안트라센 유도체를 포함하는 유기 전계발광 소자가 제공된다. According to another aspect of the present invention, there is provided an organic electroluminescent device comprising a first electrode, a second electrode, and at least one organic film disposed between the electrodes, wherein the organic film includes the anthracene derivative described above .
본 발명의 일 실시예에 따른 안트라센 유도체는 유기 전계발광 소자의 유기물층, 바람직하게는 발광효율을 개선시킬 수 있다. 특히 화합물의 열적 안정성에 의해 소자의 수명이 개선될 수 있다.An anthracene derivative according to an embodiment of the present invention can improve the organic layer, preferably the luminous efficiency, of the organic electroluminescent device. In particular, the thermal stability of the compound can improve the lifetime of the device.
도 1은 본 발명의 일 실시예에 따른 유기 전계발광 소자의 개략적인 단면도이다.
도 2는 화합물 3-1 (mks-3-8)의 LC-MS 분석결과이다.
도 3은 화합물 3-2 (mks-3-20)의 LC-MS 분석결과이다.
도 4는 화합물 3-3 (mks-3-22)의 LC-MS 분석결과이다.
도 5는 화합물 3-4 (mks-3-34)의 LC-MS 분석결과이다.
도 6은 화합물 3-5 (mks-3-36)의 LC-MS 분석결과이다.
도 7은 화합물 3-6 (mks-3-38)의 LC-MS 분석결과이다.
도 8은 화합물 3-7 (mks-3-40)의 LC-MS 분석결과이다.
도 9는 화합물 3-8 (mks-3-46)의 LC-MS 분석결과이다.
도 10은 화합물 3-9 (mks-3-48)의 LC-MS 분석결과이다.
도 11은 화합물 3-10 (mks-4-1)의 LC-MS 분석결과이다.
도 12는 화합물 3-11 (mks-4-3)의 LC-MS 분석결과이다.
도 13은 화합물 3-12 (mks-4-5)의 LC-MS 분석결과이다.
도 14는 화합물 3-13 (mks-4-7)의 LC-MS 분석결과이다.
도 15는 화합물 3-14 (mks-4-11)의 LC-MS 분석결과이다.
도 16은 화합물 3-15 (mks-4-15)의 LC-MS 분석결과이다.
도 17은 화합물 3-16 (mks-4-17)의 LC-MS 분석결과이다.
도 18은 화합물 3-17 (mks-4-19)의 LC-MS 분석결과이다.
도 19는 화합물 3-18 (mks-4-29)의 LC-MS 분석결과이다.
도 20은 화합물 3-19 (mks-4-31)의 LC-MS 분석결과이다.
도 21은 화합물 3-20 (mks-4-33)의 LC-MS 분석결과이다.
도 22는 화합물 3-21 (mks-4-35)의 LC-MS 분석결과이다.
도 23는 화합물 3-22 (mks-4-37)의 LC-MS 분석결과이다.
도 24는 화합물 3-23 (mks-6-5)의 LC-MS 분석결과이다. 1 is a schematic cross-sectional view of an organic electroluminescent device according to an embodiment of the present invention.
2 shows the results of LC-MS analysis of Compound 3-1 (mks-3-8).
3 shows the result of LC-MS analysis of Compound 3-2 (mks-3-20).
4 shows the result of LC-MS analysis of compound 3-3 (mks-3-22).
5 shows the result of LC-MS analysis of compound 3-4 (mks-3-34).
6 shows the results of LC-MS analysis of Compound 3-5 (mks-3-36).
Fig. 7 shows LC-MS analysis results of Compound 3-6 (mks-3-38).
8 shows the results of LC-MS analysis of compound 3-7 (mks-3-40).
Figure 9 shows the results of LC-MS analysis of compound 3-8 (mks-3-46).
10 shows the result of LC-MS analysis of Compound 3-9 (mks-3-48).
11 shows the results of LC-MS analysis of compound 3-10 (mks-4-1).
12 shows the results of LC-MS analysis of the compound 3-11 (mks-4-3).
13 shows the results of LC-MS analysis of Compound 3-12 (mks-4-5).
Fig. 14 shows LC-MS analysis results of compound 3-13 (mks-4-7).
15 shows the results of LC-MS analysis of compound 3-14 (mks-4-11).
16 shows the results of LC-MS analysis of Compound 3-15 (mks-4-15).
17 shows the results of LC-MS analysis of compound 3-16 (mks-4-17).
18 shows the results of LC-MS analysis of Compound 3-17 (mks-4-19).
19 shows the results of LC-MS analysis of compound 3-18 (mks-4-29).
20 shows the results of LC-MS analysis of Compound 3-19 (mks-4-31).
21 shows the results of LC-MS analysis of compound 3-20 (mks-4-33).
22 shows the results of LC-MS analysis of Compound 3-21 (mks-4-35).
23 shows the results of LC-MS analysis of the compound 3-22 (mks-4-37).
24 shows the results of LC-MS analysis of the compound 3-23 (mks-6-5).
본 명세서에서 용어 "알킬"은 직쇄, 분지쇄 또는 고리형의 탄화수소 라디칼 또는 이들의 조합을 포함하며, 경우에 따라 사슬 안에 이중 결합, 삼중 결합 또는 이들의 조합을 하나 이상 포함할 수도 있다. 즉 "알킬"은 알케닐이나 알키닐을 포함한다.As used herein, the term "alkyl" includes straight chain, branched or cyclic hydrocarbon radicals or combinations thereof, optionally including one or more double bonds, triple bonds or combinations thereof in the chain. E., "Alkyl" includes alkenyl or alkynyl.
용어 "헤테로알킬"은 그 자체로 또는 다른 용어와 조합되어, 다른 의미로 명시되지 않는 한, 1종 이상의 탄소 원자 및 O, N, P, Si 및 S로 이루어진 군으로부터 선택되는 1종 이상의 이종원자로 이루어지는 안정한 직쇄 또는 분지쇄 또는 고리형 탄화수소 라디칼 또는 이들의 조합을 의미하고, 질소, 인 및 황 원자는 임의로 산화될 수 있고, 질소 이종원자는 임의로 4차화될 수 있다.The term "heteroalkyl ", by itself or in combination with other terms, unless otherwise indicated, includes one or more carbon atoms and one or more heteroatoms selected from the group consisting of O, N, P, Si and S Means a stable straight or branched or cyclic hydrocarbon radical or combination thereof, wherein the nitrogen, phosphorus and sulfur atoms may optionally be oxidized, and the nitrogen heteroatom may optionally be quaternized.
용어 "시클로알킬" 및 "헤테로시클로알킬"은 그 자체로 또는 다른 용어와 함께, 다른 의미로 명시하지 않는 한, 각각 "알킬" 및 "헤테로알킬"의 고리형 버전을 나타낸다.The terms "cycloalkyl" and "heterocycloalkyl ", by themselves or in conjunction with another term, refer to a cyclic version of" alkyl "and" heteroalkyl ", respectively,
용어 "아릴"은 다른 의미로 명시되지 않는 한, 함께 융합 또는 공유 결합된 단일 고리 또는 다중 고리(1개 내지 3개의 고리)일 수 있는 다중불포화, 방향족, 탄화수소 치환기를 의미한다. "헤테로아릴"이란 용어는 (다중 고리의 경우 각각의 별도의 고리에서) N, O 및 S로부터 선택되는 1 내지 4개의 이종원자를 포함하는 아릴 기(또는 고리)를 의미하고, 질소 및 황 원자는 임의로 산화되고, 질소 원자(들)은 임의로 4차화된다. 헤테로아릴 기는 탄소 또는 이종원자를 통해 분자의 나머지에 결합될 수 있다.The term "aryl" means a polyunsaturated, aromatic, hydrocarbon substituent which may be a single ring or multiple rings (one to three rings) fused or covalently bonded together unless otherwise specified. The term "heteroaryl" means an aryl group (or a ring) comprising one to four heteroatoms selected from N, O and S (in each case on a separate ring in the case of multiple rings) Optionally oxidized, and the nitrogen atom (s) are optionally quaternized. Heteroaryl groups can be attached to the remainder of the molecule through carbon or heteroatoms.
상기 아릴은 각 고리에 적절하게는 4 내지 7개, 바람직하게는 5 또는 6개의 고리원자를 포함하는 단일 또는 융합고리계를 포함한다. 또한, 하나 이상의 아릴이 화학결합을 통하여 결합되어 있는 구조도 포함한다. 상기 아릴의 구체적인 예로 페닐, 나프틸, 비페닐, 안트릴, 인데닐, 플루오레닐, 페난트릴, 트라이페닐레닐, 피렌일, 페릴렌일, 크라이세닐, 나프타세닐, 플루오란텐일 등을 포함하지만, 이에 한정되지 않는다.The aryl includes a single or fused ring system, suitably containing from 4 to 7, preferably 5 or 6, ring atoms in each ring. Also included are structures in which one or more aryls are attached through a chemical bond. Specific examples of the aryl include phenyl, naphthyl, biphenyl, anthryl, indenyl, fluorenyl, phenanthryl, triphenylenyl, pyreneyl, perylenyl, But is not limited thereto.
상기 헤테로아릴은 5 내지 6원 단환 헤테로아릴, 및 하나 이상의 벤젠 환과 융합된 다환식 헤테로아릴을 포함하며, 부분적으로 포화될 수도 있다. 또한, 하나 이상의 헤테로아릴이 화학결합을 통하여 결합되어 있는 구조도 포함된다. 상기 헤테로아릴기는 고리 내 헤테로원자가 산화되거나 사원화되어, 예를 들어 N-옥사이드 또는 4차 염을 형성하는 2가 아릴 그룹을 포함한다. 상기 헤테로아릴의 구체적인 예로 퓨릴, 티오펜일, 피롤릴, 이미다졸릴, 피라졸릴, 티아졸릴, 티아디아졸릴, 이소티아졸릴, 이속사졸릴, 옥사졸릴, 옥사디아졸릴, 트리아진일, 테트라진일, 트리아졸릴, 테트라졸릴, 퓨라잔일, 피리딜, 피라진일, 피리미딘일, 피리다진일 등의 단환 헤테로아릴, 벤조퓨란일, 벤조티오펜일, 이소벤조퓨란일, 벤조이미다졸릴, 벤조티아졸릴, 벤조이소티아졸릴, 벤조이속사졸릴, 벤조옥사졸릴, 이소인돌릴, 인돌릴, 인다졸릴, 벤조티아디아졸릴, 퀴놀릴, 이소퀴놀릴, 신놀리닐, 퀴나졸리닐, 퀴녹살리닐, 카바졸릴, 페난트리딘일, 벤조디옥솔릴 등의 다환식 헤테로아릴 및 이들의 상응하는 N-옥사이드(예를 들어, 피리딜 N-옥사이드, 퀴놀릴 N-옥사이드), 이들의 4차 염 등을 포함하지만, 이에 한정되지 않는다.The heteroaryl includes 5- to 6-membered monocyclic heteroaryl and polycyclic heteroaryl fused with one or more benzene rings, and may be partially saturated. Also included are structures in which one or more heteroaryls are attached via a chemical bond. The heteroaryl groups include divalent aryl groups in which the heteroatoms in the ring are oxidized or trisubstituted to form, for example, an N-oxide or a quaternary salt. Specific examples of the heteroaryl include furyl, thiophenyl, pyrrolyl, imidazolyl, pyrazolyl, thiazolyl, thiadiazolyl, isothiazolyl, isoxazolyl, oxazolyl, oxadiazolyl, triazinyl, tetrazinyl, Monocyclic heteroaryl such as pyridyl, pyridyl, pyrazinyl, pyridazinyl and the like, benzofuranyl, benzothiophenyl, isobenzofuranyl, benzoimidazolyl, benzothiazolyl , Benzoisothiazolyl, benzoisoxazolyl, benzoxazolyl, isoindolyl, indolyl, indazolyl, benzothiadiazolyl, quinolyl, isoquinolyl, cinnolinyl, quinazolinyl, quinoxalinyl, (Such as pyridyl N-oxide, quinolyl N-oxide), quaternary salts thereof, and the like, but are not limited thereto. But is not limited thereto.
용어 "아르알킬"은 아릴 및 아릴로 치환된 알킬 그룹을 나타내며, 여기서, 알킬 및 아릴 부분은 독립적으로 임의로 치환된다.The term "aralkyl" refers to an alkyl group substituted with aryl and aryl, wherein the alkyl and aryl moieties are independently optionally substituted.
용어 "헤테로아르알킬"은 각각 아릴 및 헤테로아릴로 치환된 알킬 그룹을 나타내며, 여기서, 알킬 및 헤테로아릴 부분은 독립적으로 임의로 치환된다.The term "heteroaralkyl" refers to an alkyl group substituted with aryl and heteroaryl, respectively, wherein the alkyl and heteroaryl moieties are independently optionally substituted.
본 명세서에 기재된 "치환 또는 비치환된"이라는 표현에서 "치환"은 탄화수소 내의 수소 원자 하나 이상이 각각, 서로 독립적으로, 동일하거나 상이한 치환기로 대체되는 것을 의미한다. 유용한 치환기는 다음을 포함하지만 이에 제한되지 않는다."Substituted" in the expression " substituted or unsubstituted ", as used herein, means that at least one hydrogen atom in the hydrocarbon is each independently replaced with the same or different substituents. Useful substituents include, but are not limited to:
이러한 치환기는, -F; -Cl; -Br; -CN; -NO2 -OH; -F, -Cl, -Br, -CN, -NO2 또는 -OH로 치환되거나 비치환된 C1-C20 알킬기; -F, -Cl, -Br, -CN, -NO2 또는 -OH로 치환되거나 비치환된 C1-C20 알콕시기; C1-C20 알킬기, C1-C20 알콕시기, -F, -Cl, -Br, -CN, -NO2 또는 -OH로 치환되거나 비치환된 C6-C30 아릴기; C1-C20 알킬기, C1-C20 알콕시기, -F, -Cl, -Br, -CN, -NO2 또는 -OH로 치환되거나 비치환된 C6-C30 헤테로아릴기; C1-C20 알킬기, C1-C20 알콕시기, -F, -Cl, -Br, -CN, -NO2 또는 -OH로 치환되거나 비치환된 C5-C20 사이클로알킬기; C1-C20 알킬기, C1-C20 알콕시기, -F, -Cl, -Br, -CN, -NO2 또는 -OH로 치환되거나 비치환된 C5-C30 헤테로사이클로알킬기; 및 -N(G1)(G2)으로 표시되는 기로 이루어진 군으로부터 선택된 하나 이상일 수 있다. 이 때, 상기 G1 및 G2는 서로 독립적으로 각각 수소; C1-C10 알킬기; 또는 C1-C10 알킬기로 치환되거나 비치환된 C6-C30 아릴기일 수 있다.Such substituents include, but are not limited to, -F; -Cl; -Br; -CN; -NO 2 -OH; A C 1 -C 20 alkyl group which is unsubstituted or substituted by -F, -Cl, -Br, -CN, -NO 2 or -OH; A C 1 -C 20 alkoxy group unsubstituted or substituted with -F, -Cl, -Br, -CN, -NO 2 or -OH; A C 6 -C 30 aryl group which is unsubstituted or substituted by a C 1 -C 20 alkyl group, a C 1 -C 20 alkoxy group, -F, -Cl, -Br, -CN, -NO 2 or -OH; A C 6 -C 30 heteroaryl group which is unsubstituted or substituted by a C 1 -C 20 alkyl group, a C 1 -C 20 alkoxy group, -F, -Cl, -Br, -CN, -NO 2 or -OH; C 1 -C 20 alkyl, C 1 -C 20 alkoxy group, -F, -Cl, -Br, -CN , -NO 2 , or substituted by -OH or unsubstituted C 5 -C 20 cycloalkyl group; C 1 -C 20 alkyl, C 1 -C 20 alkoxy group, -F, -Cl, -Br, -CN , -NO 2 , or substituted by -OH or unsubstituted C 5 -C 30 heterocycloalkyl group; And a group represented by -N (G 1 ) (G 2 ). Wherein G 1 and G 2 are each independently selected from the group consisting of hydrogen; A C 1 -C 10 alkyl group; Or a C 6 -C 30 aryl group substituted or unsubstituted with a C 1 -C 10 alkyl group.
탄소 수를 나타내는 용어 중 예를 들어 "Cn-C30"은 n 내지 30개의 탄소 수를 가질 수도 있고, n 내지 20개의 탄소수를 가질 수도 있고, n 내지 10개의 탄소수를 가질 수도 있고, n 내지 6개의 탄소수를 가질 수도 있다. 마찬가지로 "Cn-C20"은 n 내지 20개의 탄소 수를 가질 수도 있고, n 내지 10개의 탄소수를 가질 수도 있고, n 내지 6개의 탄소 수를 가질 수도 있다(n은 1 내지 6의 정수).Among the terms indicating the number of carbon atoms, for example, "C n -C 30 " may have n to 30 carbon atoms, may have n to 20 carbon atoms, may have n to 10 carbon atoms, And may have 6 carbon atoms. Similarly, "C n -C 20 " may have n to 20 carbon atoms, may have n to 10 carbon atoms, and may have n to 6 carbon atoms (n is an integer of 1 to 6).
이하, 본 발명에 대해 상세히 설명하고자 한다.Hereinafter, the present invention will be described in detail.
본 발명의 일 실시예에 따른 안트라센 유도체는 하기 화학식 1로 표시될 수 있다.An anthracene derivative according to an embodiment of the present invention may be represented by the following general formula (1).
하기 화학식 1로 표시되는 안트라센 유도체가 제공된다.An anthracene derivative represented by the following formula (1) is provided.
[화학식 1][Chemical Formula 1]
상기 화학식 1에 있어서,In
R1은 수소, 할로겐, 아미노, 니트로, 시아노, 히드록시, 치환 또는 비치환된 C1-C30 알킬, 치환 또는 비치환된 C3-C30 시클로알킬, 치환 또는 비치환된 C6-C30 아릴, 치환 또는 비치환된 C6-C30 아르알킬(aralkyl), 치환 또는 비치환된 C1-C30 헤테로알킬, 치환 또는 비치환된 C2-C30 헤테로시클로알킬, 치환 또는 비치환된 C5-C30 헤테로아릴, 치환 또는 비치환된 C5-C30 헤테로아르알킬이다.R 1 is hydrogen, halogen, amino, nitro, cyano, hydroxy, substituted or unsubstituted C 1 -C 30 alkyl, substituted or unsubstituted C 3 -C 30 cycloalkyl, substituted or unsubstituted C 6 - C 30 aryl group, a substituted or unsubstituted C 6 -C 30 aralkyl (aralkyl), substituted or unsubstituted C 1 -C 30 heteroalkyl, substituted or unsubstituted C 2 -C 30 heterocycloalkyl, substituted or unsubstituted Substituted C 5 -C 30 heteroaryl, substituted or unsubstituted C 5 -C 30 heteroaralkyl.
p는 1 내지 4의 정수이다. 즉 하나의 고리에 치환된 R1은 1개 내지 4개일 수 있다. 이때 하나의 고리 내에 치환된 둘 이상의 R1은 서로 같거나 다를 수 있다. 인접한 R1은 각각 치환 또는 비치환된 C3-C20 알킬렌이나 치환 또는 비치환된 C3-C20 알케닐렌으로 서로 연결되어 융합고리를 형성할 수 있다.p is an integer of 1 to 4; That is, R 1 substituted on one ring may be one to four. Two or more R < 1 > substituted in one ring may be the same or different from each other. Adjacent R 1 are connected to each other, each substituted or unsubstituted C 3 -C 20 alkylene or a substituted or unsubstituted C 3 -C 20 alkenylene may form a fused ring.
L1 및 L2는 각각 독립적으로 화학 결합, 치환 또는 비치환된 C6-C30 아릴이거나 치환 또는 비치환된 C6-C30 헤테로아릴이다. 예를 들어, L1 및 L2는 각각 페닐 또는 안트라세닐이다.L 1 and L 2 are each independently a chemical bond, a substituted or unsubstituted C 6 -C 30 aryl, or a substituted or unsubstituted C 6 -C 30 heteroaryl. For example, L 1 and L 2 are each phenyl or anthracenyl.
Ar은 치환 또는 비치환된 C6-C30 아릴이거나 치환 또는 비치환된 C6-C30 헤테로아릴이다.Ar is a substituted or unsubstituted C 6 -C 30 aryl or a substituted or unsubstituted C 6 -C 30 heteroaryl group.
일 구현예에서, 상기 Ar은 , , , , , , , 또는 일 수 있다.In one embodiment, Ar is < RTI ID = 0.0 > , , , , , , , or Lt; / RTI >
한편, R2, R3, R4 및 R5는 각각 독립적으로 상기 R1의 정의와 같다.R 2 , R 3 , R 4 and R 5 are each independently the same as defined for R 1 above.
또한 q, r, s 및 t는 각각 독립적으로 1 내지 5의 정수 중에서 선택되며, R2, R3, R4 또는 R5기가 붙어 있는 고리의 종류에 따라 최대값이 3, 4 또는 5일 수 있다.And q, r, s and t are each independently selected from the integers of 1 to 5, and the maximum value is 3, 4 or 5 days depending on the type of ring to which R 2 , R 3 , R 4 or R 5 groups are attached have.
상기 화학식 1로 표시되는 화합물은 구체적으로 하기 화학식 2의 구조들 중에서 선택될 수 있다.The compound represented by
[화학식 2](2)
상기 화학식 2에 있어서, R1, p 및 Ar은 상기 화학식 1에서 정의한 바와 같다.In
상기 화학식 1 또는 화학식 2의 몇몇 구현예에 있어서, 상기 R1, R2, R3, R4 및 R5는 수소일 수 있다.In some embodiments of
더욱 상세하게는, 상기 화학식 1로 표시되는 화합물은 하기 화학식 3으로 표시되는 화합물들 중 하나에서 선택될 수 있으나 이에 한정되는 것은 아니다.More specifically, the compound represented by
[화학식 3](3)
상기 화학식 1로 표시되는 안트라센 유도체는 공지의 유기 합성방법을 이용하여 합성가능하다. 상기 안트라센 유도체의 합성방법은 후술하는 제조예를 참조하여 당업자에게 용이하게 인식될 수 있다.The anthracene derivative represented by the above formula (1) can be synthesized using a known organic synthesis method. The method for synthesizing the anthracene derivative can be easily recognized by those skilled in the art with reference to the following production examples.
또한 본 발명에 따르면, 상기 화학식 1로 표시되는 안트라센 유도체를 포함하는 유기 전계발광 소자가 제공된다. Also, according to the present invention, there is provided an organic electroluminescent device comprising an anthracene derivative represented by the above formula (1).
상기 화학식 1의 안트라센 유도체는 바람직하게는 발광층의 청색 형광 도판트 및 호스트 재료로서 유용하게 사용될 수 있다. The anthracene derivative of
또한 본 발명에 따른 유기 전계발광 소자는 제1 전극, 제2 전극 및 이들 전극 사이에 배치된 1층 이상의 유기막을 포함한다. 상기 유기막은 상기 화학식 1로 표시되는 안트라센 유도체를 하나 이상 포함한다.The organic electroluminescent device according to the present invention includes a first electrode, a second electrode, and at least one organic film disposed between the electrodes. The organic layer includes at least one anthracene derivative represented by the general formula (1).
상기 유기막은 정공주입층, 정공수송층, 정공주입 기능과 정공수송 기능을 동시에 갖는 기능층, 버퍼층, 전자저지층, 발광층, 정공저지층, 전자수송층, 전자주입층, 및 전자수송 기능과 전자주입 기능을 동시에 갖는 기능층으로 이루어진 군 중에서 선택되는 1층 이상을 포함할 수 있다.The organic layer includes a hole injecting layer, a hole transporting layer, a functional layer having both a hole injecting function and a hole transporting function, a buffer layer, an electron blocking layer, a light emitting layer, a hole blocking layer, an electron transporting layer, And at least one layer selected from the group consisting of functional layers having at the same time.
본 발명에 따른 유기 전계발광소자는 양극/발광층/음극, 양극/정공주입층/발광층/음극, 양극/정공주입층/정공수송층/발광층/전자수송층/음극, 또는 양극/정공주입층/정공수송층/발광층/전자수송층/전자주입층/음극의 구조를 가질 수 있다. 또는 상기 유기 전계 발광 장치는 양극/정공주입 기능 및 정공수송 기능을 동시에 갖는 기능층/발광층/전자수송층/음극, 또는 양극/정공주입 기능 및 정공 수송 기능을 동시에 갖는 기능층/발광층/전자수송층/전자주입층/음극의 구조를 가질 수 있지만 이에 한정되는 것은 아니다.The organic electroluminescent device according to the present invention can be applied to an organic electroluminescent device including a positive electrode / a light emitting layer / a cathode, a positive electrode / a hole injecting layer / a light emitting layer / a negative electrode, an anode / a hole injecting layer / a hole transporting layer / a light emitting layer / an electron transporting layer / / Light emitting layer / electron transporting layer / electron injecting layer / cathode structure. Alternatively, the organic electroluminescent device may include a functional layer / a light emitting layer / an electron transporting layer / a cathode having both an anode / hole injecting function and a hole transporting function, or a functional layer / a light emitting layer / an electron transporting layer / Electron injecting layer / cathode structure, but the present invention is not limited thereto.
도 1은 본 발명의 일 실시예에 따른 유기 전계발광 소자의 개략적인 단면도이다.1 is a schematic cross-sectional view of an organic electroluminescent device according to an embodiment of the present invention.
상기 유기 전계발광 소자는 스퍼터링(sputtering)이나 전자빔 증발(e-beam evaporation)과 같은 PVD(physical vapor deposition) 방법을 이용하여 제조될 수 있다. 예를 들어, 기판 상에 금속 또는 전도성을 가지는 금속 산화물 또는 이들의 합금을 증착시켜 양극을 형성하고, 그 위에 정공주입층, 정공수송층, 발광층, 전자수송층 및 전자주입층을 포함하는 유기물층을 형성한 후, 그 위에 음극으로 사용할 수 있는 물질을 증착시킴으로써 제조될 수 있다. 이와 같은 방법 외에도, 기판 상에 음극 물질부터 유기막, 양극 물질을 차례로 증착시켜 유기 전계발광 소자를 만들 수도 있다.The organic electroluminescent device may be manufactured using a physical vapor deposition (PVD) method such as sputtering or e-beam evaporation. For example, an anode is formed by depositing a metal or a metal oxide having conductivity or an alloy thereof on a substrate, and an organic material layer including a hole injecting layer, a hole transporting layer, a light emitting layer, an electron transporting layer, and an electron injecting layer is formed thereon And then depositing a material which can be used as a cathode thereon. In addition to such a method, an organic electroluminescent device may be formed by sequentially depositing a cathode material, an organic film, and a cathode material on a substrate.
한편, 상기 유기막은 다양한 고분자 소재를 사용하여 증착법이 아닌 용액 공정(solvent process), 예컨대 스핀 코팅, 딥 코팅, 닥터 블레이딩, 스크린 프린팅, 잉크젯 프린팅 또는 열 전사법 등의 방법으로 제조될 수 있다.The organic layer may be prepared by a variety of polymer materials, not by vapor deposition, but by a solvent process such as spin coating, dip coating, doctor blading, screen printing, inkjet printing, or thermal transfer.
본 발명에 따른 유기 전계발광 소자는 사용되는 재료에 따라 전면 발광형, 후면 발광형 또는 양면 발광형일 수 있다.
The organic electroluminescent device according to the present invention may be a front emission type, a back emission type, or a both-sided emission type, depending on the material used.
이하, 다양한 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 하나, 이하의 실시예는 본 발명을 예시하기 위한 것이며, 본 발명의 범위가 이들로 한정되는 것은 아니다.
Hereinafter, the present invention will be described in more detail with reference to the following examples. However, the following examples are intended to illustrate the present invention and the scope of the present invention is not limited thereto.
합성예 1: 화합물 3-1 (mks-3-8)의 합성Synthesis Example 1: Synthesis of Compound 3-1 (mks-3-8)
mks-3-8의 합성 경로를 이하에 나타낸다.The synthesis route of mks-3-8 is shown below.
(중간체 (1)의 합성)(Synthesis of Intermediate (1 )
9-브로모안트라센 5.14 g(20.0 mmol)과 페닐보로닉산 2.56 g(22.0 mmol)에 톨루엔 50 mL와 에탄올 20 mL, 테트라키스트라이페닐포스핀팔라듐 0.73 g(0.63 mmol) 그리고 2M 탄산칼륨 수용액 20 mL를 가하여 12시간 동안 환류 교반하였다. 반응액을 상온으로 냉각하여 톨루엔 150 mL를 가한 후 물 200 mL와 포화소금물 100 mL로 유기층을 세척하고 무수황산마그네슘으로 건조, 여과하였다. 여과액을 감압 농축한 후 농축잔류물에 에틸아세테이트 50 mL를 가하고 70℃로 승온하여 용해하였다. 이 용해액을 상온으로 서서히 냉각하여 2시간 동안 교반한 후 생성된 고체를 감압 여과하고 건조하여 중간체 (1) 4.10 g(수율 81%)을 얻었다.
50 mL of toluene and 20 mL of ethanol, 0.73 g (0.63 mmol) of tetrakis triphenylphosphine palladium and 2 M aqueous potassium carbonate solution (20 mL) were added to 5.14 g (20.0 mmol) of 9- bromoanthracene and 2.56 g mL, and the mixture was refluxed for 12 hours. The reaction solution was cooled to room temperature, 150 mL of toluene was added, and the organic layer was washed with 200 mL of water and 100 mL of saturated brine, dried over anhydrous magnesium sulfate, and filtered. After the filtrate was concentrated under reduced pressure, 50 mL of ethyl acetate was added to the concentrated residue, and the mixture was heated to 70 DEG C and dissolved. The resulting solution was slowly cooled to room temperature and stirred for 2 hours. The resulting solid was filtered under reduced pressure and dried to obtain 4.10 g (yield: 81%) of intermediate (1) .
(중간체 (2)의 합성)(Synthesis of Intermediate (2 )
클로로포름 150 mL에 화합물(1) 4.1 g(16.1 mmol)과 NBS 3.16 g(17.7 mmol)을 넣고 3시간 동안 환류 교반하였다. 반응액을 상온으로 냉각한 후 물 200 mL로 세척하고 무수황산마그네슘으로 건조, 여과하였다. 여과액을 감압 농축한 후 잔류물을 디클로로메탄으로 녹여 메탄올로 재결정하고 여과, 건조하여 화합물(2) 4.71 g(수율 88%)을 얻었다.
4.1 g (16.1 mmol) of the compound (1) and 3.16 g (17.7 mmol) of NBS were added to 150 mL of chloroform and the mixture was refluxed for 3 hours. The reaction solution was cooled to room temperature, washed with 200 mL of water, dried over anhydrous magnesium sulfate, and filtered. The filtrate was concentrated under reduced pressure, and the residue was dissolved in dichloromethane. The residue was recrystallized from methanol, filtered and dried to obtain 4.71 g (yield: 88%) of Compound (2) .
(최종 화합물의 합성)(Synthesis of final compound)
화합물(2) 0.50 g(1.50 mmol)과 3-(5H-피리도[3,2-b]인돌-5-일)페닐보로닉산피나콜에스테르(3-(5H-pyrido[3,2-b]indol-5-yl)phenylboronic acid pinacol ester) 0.61 g(1.65 mmol)을 톨루엔 5 mL와 에탄올 2 mL에 녹이고 테트라키스트리페닐포스핀팔라듐 0.052 g(0.045 mmol)과 2M 탄산칼륨 수용액 2 mL를 가하여 12시간 동안 환류 교반하였다. 반응 혼합물을 상온으로 냉각한 후 톨루엔 50 mL를 가하고, 유기층을 물로 세척하고 감압 농축하였다. 농축 잔류물을 디클로로메탄에 녹여 노말헥산으로 재결정하고 여과, 건조하여 화합물(3-1, mks-3-8) 0.35 g(수율 47%)을 얻었다.A solution of 0.50 g (1.50 mmol) of the compound (2) and 3- (5H-pyrido [3,2- b] indol-5-yl) phenylboronic acid pinacol ester b] indol-5-yl) phenylboronic acid pinacol ester (0.61 g, 1.65 mmol) was dissolved in 5 mL of toluene and 2 mL of ethanol, 0.052 g (0.045 mmol) of tetrakistriphenylphosphine palladium and 2 mL of a 2M aqueous potassium carbonate solution And the mixture was refluxed for 12 hours. After the reaction mixture was cooled to room temperature, 50 mL of toluene was added thereto, and the organic layer was washed with water and concentrated under reduced pressure. The concentrated residue was dissolved in dichloromethane, recrystallized from n-hexane, filtered, and dried to obtain 0.35 g (yield 47%) of the compound (3-1, mks-3-8) .
LC-MS: [M+H]+= 497.42 (도 2 참조).LC-MS: [M + H] < + > = 497.42 (see Fig. 2).
합성예 2: 화합물 3-2 (msk-3-20)의 합성Synthesis Example 2: Synthesis of Compound 3-2 (msk-3-20)
msk-3-20의 합성 경로를 이하에 나타낸다.The synthesis route of msk-3-20 is shown below.
(중간체 (3)의 합성)(Synthesis of Intermediate (3 )
9-브로모안트라센 14.24 g(55.4 mmol)과 나프탈렌-1-보로닉산 10.48 g(60.9 mmol)에 톨루엔 150 mL와 에탄올 40 mL, 테트라키스트라이페닐포스핀팔라듐 1.92 g(1.66 mmol) 그리고 2M 탄산칼륨 수용액 80 mL를 가하여 24시간 동안 환류 교반하였다. 반응액을 상온으로 냉각하여 톨루엔 500 mL를 가한 후 물 200 mL로 유기층을 세척하고 무수황산마그네슘으로 건조, 여과하였다. 여과액을 감압 농축한 후 농축잔류물에 에틸아세테이트 140 mL와 이소프로필알콜 140 mL를 가하고 75℃로 승온하여 용해하였다. 이 용해액을 상온으로 서서히 냉각하여 일야 방치한 후 생성된 고체를 감압 여과하고 건조하여 화합물(3) 9.70 g(수율 56%)을 얻었다.
To 14.24 g (55.4 mmol) of 9-bromoanthracene and 10.48 g (60.9 mmol) of naphthalene-1-boronic acid were added 150 mL of toluene and 40 mL of ethanol, 1.92 g (1.66 mmol) of tetrakis triphenylphosphine palladium and
(중간체 (4)의 합성)(Synthesis of Intermediate (4 )
클로로포름 300 mL에 화합물(3) 9.70 g(31.9 mmol)과 NBS 6.25 g(35.1 mmol)을 넣고 3시간 동안 환류 교반하였다. 반응액을 상온으로 냉각한 후 물 300 mL로 세척하고 무수황산마그네슘으로 건조, 여과하였다. 여과액을 감압 농축한 후 잔류물을 디클로로메탄으로 녹여 메탄올로 재결정하고 여과, 건조하여 화합물(4) 10.66 g(수율 87%)을 얻었다.
9.70 g (31.9 mmol) of the compound (3) and 6.25 g (35.1 mmol) of NBS were added to 300 mL of chloroform and the mixture was stirred under reflux for 3 hours. The reaction solution was cooled to room temperature, washed with 300 mL of water, dried over anhydrous magnesium sulfate, and filtered. The filtrate was concentrated under reduced pressure. The residue was dissolved in dichloromethane, recrystallized from methanol, filtered, and dried to obtain 10.66 g (yield: 87%) of compound (4) .
(중간체 (5)의 합성)(Synthesis of intermediate 5 )
화합물(4) 5.0 g(13.0 mmol)을 무수 테트라하이드로퓨란 200 mL에 녹이고 -78℃로 냉각하였다. 여기에 n-부틸리튬(1.6M 노말헥산용액) 9.8 mL(15.7 mmol)를 서서히 가하여 30분간 교반한 후 트리에틸보레이트 2.66 g(18.2 mmol)을 가하고 일야 교반하였다. 2N 염산용액 20 mL를 가하여 1시간 동안 교반한 후 유기층을 분리하였다. 유기층을 에틸아세테이트 800 mL로 희석하고 물로 세척한 후 무수황산마그네슘으로 건조, 여과하여 감압 농축하였다. 농축 잔류물을 디클로로메탄에 녹여 노말헥산으로 재결정화하고 여과, 건조하여 화합물(5) 2.08 g(수율 46%)을 얻었다.
5.0 g (13.0 mmol) of the compound (4) was dissolved in 200 mL of anhydrous tetrahydrofuran and cooled to -78 ° C. 9.8 mL (15.7 mmol) of n-butyllithium (1.6 M normal hexane solution) was slowly added thereto, and the mixture was stirred for 30 minutes. Then, 2.66 g (18.2 mmol) of triethylborate was added and stirred overnight. 20 mL of a 2N hydrochloric acid solution was added and the mixture was stirred for 1 hour, and then the organic layer was separated. The organic layer was diluted with ethyl acetate (800 mL), washed with water, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The concentrated residue was dissolved in dichloromethane, recrystallized from n-hexane, filtered and dried to obtain 2.08 g (yield 46%) of compound (5) .
(최종 화합물의 합성)(Synthesis of final compound)
화합물(6) 0.50 g(1.44 mmol)과 5-(3-브로모페닐)-5H-피리도[3,2-b]인돌(5-(3-bromophenyl)-5H-pyrido[3,2-b]indole) 0.39 g(1.20 mmol)을 톨루엔 5 mL와 에탄올 2 mL에 녹이고 테트라키스트리페닐포스핀팔라듐 0.042 g(0.036 mmol)과 2M 탄산칼륨 수용액 2 mL를 가하여 18시간 동안 환류 교반하였다. 반응 혼합물을 상온으로 냉각한 후 디클로로메탄 50 mL를 가하고, 유기층을 물로 세척하고 감압 농축하였다. 농축 잔류물에 톨루엔 10 mL를 가하고 1시간 동안 교반하여 침전을 생성시킨 후 감압 여과하였다. 여과한 침전을 디클로로메탄에 녹여 노말헥산으로 재결정하고 여과, 건조하여 화합물(3-2, mks-3-20) 0.24 g(수율 37%)을 얻었다.(3-bromophenyl) -5H-pyrido [3,2-b] indole was obtained by reacting 0.50 g (1.44 mmol) of the compound (6) b] indole (0.39 g, 1.20 mmol) was dissolved in 5 mL of toluene and 2 mL of ethanol, 0.042 g (0.036 mmol) of tetrakistriphenylphosphine palladium and 2 mL of 2M potassium carbonate aqueous solution were added thereto and the mixture was refluxed with stirring for 18 hours. After the reaction mixture was cooled to room temperature, 50 mL of dichloromethane was added thereto, and the organic layer was washed with water and concentrated under reduced pressure. To the concentrated residue was added 10 mL of toluene and stirred for 1 hour to form a precipitate, which was then filtered under reduced pressure. The precipitate obtained by filtration was dissolved in dichloromethane, recrystallized with n-hexane, filtered and dried to obtain 0.24 g (yield 37%) of the compound ( 3-2, mks-3-20) .
LC-MS: [M+H]+= 547.45 (도 3 참조).LC-MS: [M + H] < + > = 547.45 (see Fig. 3).
합성예 3: 화합물 3-3 (msk-3-22)의 합성Synthesis Example 3: Synthesis of Compound 3-3 (msk-3-22)
msk-3-22의 합성 경로를 이하에 나타낸다.
The synthesis route of msk-3-22 is shown below.
(중간체 (6)의 합성)(Synthesis of Intermediate (6 )
9-브로모안트라센 14.24 g(55.4 mmol)과 나프탈렌-2-보로닉산 10.48 g(60.9 mmol)에 톨루엔 150 mL와 에탄올 40 mL, 테트라키스트라이페닐포스핀팔라듐 1.92 g(1.66 mmol) 그리고 2M 탄산칼륨 수용액 80 mL를 가하여 12시간 동안 환류 교반하였다. 반응 혼합물을 상온으로 냉각한 후 생성된 침전을 감압 여과하고 톨루엔, 물, 메탄올로 세척하였다. 여과된 침전을 디클로로메탄에 녹여 메탄올로 재결정하고 여과, 건조하여 화합물(6) 13.15 g(수율 78%)을 얻었다.
To 14.24 g (55.4 mmol) of 9-bromoanthracene and 10.48 g (60.9 mmol) of naphthalene-2-boronic acid were added 150 mL of toluene and 40 mL of ethanol, 1.92 g (1.66 mmol) of tetrakis triphenylphosphine palladium and
(중간체 (7)의 합성)(Synthesis of intermediate 7 )
클로로포름 400 mL에 화합물(6) 13.15 g(43.2 mmol)과 NBS 8.48 g(47.5 mmol)을 넣고 6시간 동안 환류 교반하였다. 반응액을 상온으로 냉각한 후 물 400 mL로 세척하고 무수황산마그네슘으로 건조, 여과하였다. 여과액을 감압 농축한 후 잔류물을 클로로포름으로 녹여 메탄올로 재결정하고 여과, 건조하여 화합물(7) 15.42 g(수율 93%)을 얻었다.
13.15 g (43.2 mmol) of the compound (6) and 8.48 g (47.5 mmol) of NBS were added to 400 mL of chloroform and the mixture was refluxed with stirring for 6 hours. The reaction solution was cooled to room temperature, washed with 400 mL of water, dried over anhydrous magnesium sulfate, and filtered. After the filtrate was concentrated under reduced pressure, the residue was dissolved in chloroform, and the residue was recrystallized from methanol, followed by filtration and drying to obtain 15.42 g (yield 93%) of compound (7) .
(최종 화합물의 합성)(Synthesis of final compound)
화합물(7) 0.50 g(1.30 mmol)과 3-(5H-피리도[3,2-b]인돌-5-일)페닐보로닉산피나콜에스테르(3-(5H-pyrido[3,2-b]indol-5-yl)phenylboronic acid pinacol ester) 0.53 g(1.43 mmol)을 톨루엔 5 mL와 에탄올 2 mL에 녹이고 테트라키스트리페닐포스핀팔라듐 0.045 g(0.039 mmol)과 2M 탄산칼륨 수용액 2 mL를 가하여 12시간 동안 환류 교반하였다. 반응 혼합물을 상온으로 냉각한 후 생성된 침전을 감압 여과하고 톨루엔, 물, 메탄올로 세척하였다. 여과된 침전을 클로로포름에 녹이고 클로로포름이 약 10 mL가 남을 때까지 서서히 감압 농축하였다. 생성된 침전을 감압 여과하고 건조하여 화합물(3-3, mks-3-22) 0.37 g(수율 52%)을 얻었다.A solution of 0.50 g (1.30 mmol) of the compound (7) and 3- (5H-pyrido [3,2- b] indol-5-yl) phenylboronic acid pinacol ester b] indol-5-yl) phenylboronic acid pinacol ester (0.53 g, 1.43 mmol) was dissolved in 5 mL of toluene and 2 mL of ethanol, and 0.045 g (0.039 mmol) of tetrakistriphenylphosphine palladium and 2 mL of a 2M aqueous potassium carbonate solution And the mixture was refluxed for 12 hours. The reaction mixture was cooled to room temperature and the resulting precipitate was filtered under reduced pressure and washed with toluene, water, and methanol. The filtered precipitate was dissolved in chloroform and the solution was gradually concentrated under reduced pressure until about 10 mL of chloroform remained. The resulting precipitate was filtered under reduced pressure and dried to obtain 0.37 g (yield: 52%) of the compound ( 3-3, mks-3-22 ).
LC-MS: [M+H]+= 547.45(도 4 참조).LC-MS: [M + H] < + > = 547.45 (see Fig. 4).
합성예 4: 화합물 3-4 (msk-3-34)의 합성Synthesis Example 4: Synthesis of compound 3-4 (msk-3-34)
msk-3-34의 합성 경로를 이하에 나타낸다.The synthesis route of msk-3-34 is shown below.
(최종 화합물의 합성)(Synthesis of final compound)
화합물(4) 0.47 g(1.23 mmol)과 4-(5H-피리도[3,2-b]인돌-5-일)페닐보로닉산피나콜에스테르(4-(5H-pyrido[3,2-b]indol-5-yl)phenylboronic acid pinacol ester) 0.50 g(1.35 mmol)을 톨루엔 5 mL와 에탄올 2 mL에 녹이고 테트라키스트리페닐포스핀팔라듐 0.043 g(0.037 mmol)과 2M 탄산칼륨 수용액 2 mL를 가하여 12시간 동안 환류 교반하였다. 반응 혼합물을 상온으로 냉각한 후 디클로로메탄 50 mL를 가하고, 유기층을 물로 세척하고 감압 농축하였다. 농축 잔류물을 클로로포름에 녹여 메탄올로 재결정하고 여과, 건조하여 화합물(3-4, mks-3-34) 0.31 g(수율 46%)을 얻었다.A solution of 0.47 g (1.23 mmol) of the compound (4) and 4- (5H-pyrido [3,2- b] indol-5-yl) phenylboronic acid pinacol ester b] indol-5-yl) phenylboronic acid pinacol ester (0.50 g, 1.35 mmol) was dissolved in 5 mL of toluene and 2 mL of ethanol, and 0.043 g (0.037 mmol) of tetrakistriphenylphosphine palladium and 2 mL of a 2M aqueous potassium carbonate solution And the mixture was refluxed for 12 hours. After the reaction mixture was cooled to room temperature, 50 mL of dichloromethane was added thereto, and the organic layer was washed with water and concentrated under reduced pressure. The concentrated residue was dissolved in chloroform, recrystallized from methanol, filtered and dried to obtain 0.31 g (yield 46%) of the compound ( 3-4, mks-3-34 ).
LC-MS: [M+H]+= 547.45(도 5 참조).
LC-MS: [M + H] < + > = 547.45 (see Fig. 5).
합성예 5: 화합물 3-5 (msk-3-36)의 합성Synthesis Example 5: Synthesis of Compound 3-5 (msk-3-36)
msk-3-36의 합성 경로를 이하에 나타낸다.The synthesis route of msk-3-36 is shown below.
(최종 화합물의 합성)(Synthesis of final compound)
화합물(7) 0.47 g(1.23 mmol)과 4-(5H-피리도[3,2-b]인돌-5-일)페닐보로닉산피나콜에스테르(4-(5H-pyrido[3,2-b]indol-5-yl)phenylboronic acid pinacol ester) 0.50 g(1.35 mmol)을 톨루엔 5 mL와 에탄올 2 mL에 녹이고 테트라키스트리페닐포스핀팔라듐 0.043 g(0.037 mmol)과 2M 탄산칼륨 수용액 2 mL를 가하여 12시간 동안 환류 교반하였다. 반응 혼합물을 상온으로 냉각한 후 디클로로메탄 50 mL를 가하고, 유기층을 물로 세척하고 감압 농축하였다. 농축 잔류물을 클로로포름에 녹여 메탄올로 재결정하고 여과, 건조하여 화합물(3-5, mks-3-36) 0.32 g(수율 48%)을 얻었다.A solution of 0.47 g (1.23 mmol) of compound (7) and 4- (5H-pyrido [3,2- b] indol-5-yl) phenylboronic acid pinacol ester b] indol-5-yl) phenylboronic acid pinacol ester (0.50 g, 1.35 mmol) was dissolved in 5 mL of toluene and 2 mL of ethanol, and 0.043 g (0.037 mmol) of tetrakistriphenylphosphine palladium and 2 mL of a 2M aqueous potassium carbonate solution And the mixture was refluxed for 12 hours. After the reaction mixture was cooled to room temperature, 50 mL of dichloromethane was added thereto, and the organic layer was washed with water and concentrated under reduced pressure. The concentrated residue was dissolved in chloroform and recrystallized from methanol, followed by filtration and drying to obtain 0.32 g (yield: 48%) of the compound ( 3-5, mks-3-36 ).
LC-MS: [M+H]+= 547.45 (도 6 참조).
LC-MS: [M + H] < + > = 547.45 (see Fig. 6).
합성예 6: 화합물 3-6 (msk-3-38)의 합성Synthesis Example 6: Synthesis of Compound 3-6 (msk-3-38)
msk-3-38의 합성 경로를 이하에 나타낸다.
The synthesis route of msk-3-38 is shown below.
(최종 화합물의 합성)(Synthesis of final compound)
화합물(2) 0.41 g(1.23 mmol)과 4-(5H-피리도[3,2-b]인돌-5-일)페닐보로닉산피나콜에스테르(4-(5H-pyrido[3,2-b]indol-5-yl)phenylboronic acid pinacol ester) 0.50 g(1.35 mmol)을 톨루엔 5 mL와 에탄올 2 mL에 녹이고 테트라키스트리페닐포스핀팔라듐 0.043 g(0.037 mmol)과 2M 탄산칼륨 수용액 2 mL를 가하여 12시간 동안 환류 교반하였다. 반응 혼합물을 상온으로 냉각한 후 생성된 침전을 감압 여과하고 톨루엔, 물, 메탄올로 세척하였다. 여과된 침전을 클로로포름에 녹여 메탄올로 재결정하고 여과, 건조하여 화합물(3-6, mks-3-38) 0.41 g(수율 67%)을 얻었다.A solution of 0.41 g (1.23 mmol) of the compound (2) and 4- (5H-pyrido [3,2- b] indol-5-yl) phenylboronic acid pinacol ester b] indol-5-yl) phenylboronic acid pinacol ester (0.50 g, 1.35 mmol) was dissolved in 5 mL of toluene and 2 mL of ethanol, and 0.043 g (0.037 mmol) of tetrakistriphenylphosphine palladium and 2 mL of a 2M aqueous potassium carbonate solution And the mixture was refluxed for 12 hours. The reaction mixture was cooled to room temperature and the resulting precipitate was filtered under reduced pressure and washed with toluene, water, and methanol. The filtered precipitate was dissolved in chloroform, recrystallized from methanol, filtered and dried to obtain 0.41 g (yield 67%) of the compound ( 3-6, mks-3-38 ).
LC-MS: [M+H]+= 497.42 (도 7 참조).
LC-MS: [M + H] < + > = 497.42 (see Fig. 7).
합성예 7: 화합물 3-7 (msk-3-40)의 합성Synthesis Example 7: Synthesis of Compound 3-7 (msk-3-40)
msk-3-40의 합성 경로를 이하에 나타낸다.The synthesis route of msk-3-40 is shown below.
(중간체 (8)의 합성)(Synthesis of Intermediate (8 )
9-브로모안트라센 3.86 g(15.0 mmol)과 4-(4,5-디페닐-4H-1,2,4-트리아졸-3-일)페닐보로닉산피나콜에스테르(4-(4,5-diphenyl-4H-1,2,4-triazol-3-yl)phenylboronic acid pinacol ester) 7.0 g(16.5 mmol)에 톨루엔 37 mL와 테트라키스트라이페닐포스핀팔라듐 0.52 g(0.45 mmol) 그리고 2M 탄산칼륨 수용액 15 mL를 가하여 12시간 동안 환류 교반하였다. 반응 혼합물을 상온으로 냉각한 후 생성된 침전을 감압 여과하고 톨루엔, 물, 메탄올로 세척하였다. 여과된 침전에 클로로포름 210 mL와 NBS 2.80 g(15.7 mmol)을 넣고 6시간 동안 환류 교반하였다. 반응액을 상온으로 냉각한 후 물 200 mL로 세척하고 무수황산마그네슘으로 건조, 여과하였다. 여과액을 감압 농축한 후 잔류물을 클로로포름으로 녹여 에탄올로 재결정하고 여과, 건조하여 화합물(8) 5.75 g(수율 69%)을 얻었다.
A solution of 3.86 g (15.0 mmol) of 9-bromoanthracene and 4- (4,5-diphenyl-4H-1,2,4-triazol-3-yl) phenylboronic acid pinacol ester (4- To 7.0 g (16.5 mmol) of toluene were added 37 mL of toluene, 0.52 g (0.45 mmol) of tetrakis (triphenylphosphine) palladium and 2M carbonic acid Potassium aqueous solution (15 mL) was added and the mixture was refluxed and stirred for 12 hours. The reaction mixture was cooled to room temperature and the resulting precipitate was filtered under reduced pressure and washed with toluene, water, and methanol. 210 mL of chloroform and 2.80 g (15.7 mmol) of NBS were added to the filtered precipitate, and the mixture was refluxed for 6 hours. The reaction solution was cooled to room temperature, washed with 200 mL of water, dried over anhydrous magnesium sulfate, and filtered. The filtrate was concentrated under reduced pressure, and the residue was dissolved in chloroform. The residue was recrystallized from ethanol, filtered and dried to obtain 5.75 g (yield 69%) of Compound (8) .
(최종 화합물의 합성)(Synthesis of final compound)
화합물(8) 0.50 g(0.91 mmol)과 4-(5H-피리도[3,2-b]인돌-5-일)페닐보로닉산피나콜에스테르(4-(5H-pyrido[3,2-b]indol-5-yl)phenylboronic acid pinacol ester) 0.37 g(1.00 mmol)을 톨루엔 5 mL와 에탄올 2 mL에 녹이고 테트라키스트리페닐포스핀팔라듐 0.031 g(0.027 mmol)과 2M 탄산칼륨 수용액 1 mL를 가하여 12시간 동안 환류 교반하였다. 반응 혼합물을 상온으로 냉각한 후 생성된 침전을 감압 여과하고 톨루엔, 물, 메탄올로 세척하였다. 여과된 침전을 클로로포름에 녹이고 노말헥산으로 재결정하여 여과한 후 컬럼크로마토그래피(에틸아세테이트/노말헥산 1:1)로 주 생성물을 분리하여 화합물(3-7, mks-3-40) 0.24 g(수율 37%)을 얻었다.A mixture of 0.50 g (0.91 mmol) of the compound (8) and 4- (5H-pyrido [3,2- b] indol-5-yl) phenylboronic acid pinacol ester (4- b] indol-5-yl) phenylboronic acid pinacol ester (0.37 g, 1.00 mmol) was dissolved in 5 mL of toluene and 2 mL of ethanol, 0.031 g (0.027 mmol) of tetrakistriphenylphosphine palladium and 1 mL of a 2M aqueous potassium carbonate solution And the mixture was refluxed for 12 hours. The reaction mixture was cooled to room temperature and the resulting precipitate was filtered under reduced pressure and washed with toluene, water, and methanol. The filtered precipitate was dissolved in chloroform, recrystallized with n-hexane, filtered, and then the main product was separated by column chromatography (ethyl acetate / normal hexane 1: 1) to obtain 0.24 g of a compound ( 3-7, mks- 3-40 ) 37%).
LC-MS: [M+H]+= 716.57(도 8 참조).LC-MS: [M + H] < + > = 716.57 (see Fig. 8).
합성예 8: 화합물 3-8 (msk-3-46)의 합성Synthesis Example 8: Synthesis of Compound 3-8 (msk-3-46)
msk-3-46의 합성 경로를 이하에 나타낸다.The synthesis route of msk-3-46 is shown below.
(중간체 (9)의 합성)(Synthesis of intermediate 9 )
안트라센-9-보로닉산 5.28 g(23.9 mmol)과 9-(4-브로모페닐)카바졸 7.0 g(21.7 mmol)에 톨루엔 50 mL와 에탄올 25 mL, 테트라키스트라이페닐포스핀팔라듐 0.75 g(0.65 mmol) 그리고 2M 탄산칼륨 수용액 25 mL를 가하여 12시간 동안 환류 교반하였다. 반응액을 상온으로 냉각하여 톨루엔 450 mL를 가한 후 물 150 mL로 유기층을 세척하고 무수황산마그네슘으로 건조, 여과하였다. 톨루엔이 30 mL가 남을 때까지 서서히 감압 농축한 후 1시간 동안 상온에서 교반하였다. 생성된 침전을 감압 여과한 후 습체를 클로로포름에 녹여 메탄올로 재결정하고 여과, 건조하여 화합물(9) 6.45 g(수율 71%)을 얻었다.
To a mixture of 5.28 g (23.9 mmol) of anthracene-9-boronic acid and 7.0 g (21.7 mmol) of 9- (4-bromophenyl) carbazole were added 50 mL of toluene and 25 mL of ethanol, 0.75 g of tetrakis triphenylphosphine palladium mmol) and 25 mL of a 2M aqueous potassium carbonate solution were added, and the mixture was refluxed with stirring for 12 hours. The reaction solution was cooled to room temperature, and 450 mL of toluene was added thereto. The organic layer was washed with 150 mL of water, dried over anhydrous magnesium sulfate, and filtered. The mixture was gradually concentrated under reduced pressure until 30 mL of toluene remained, and then stirred at room temperature for 1 hour. The resulting precipitate was filtered under reduced pressure, and the wet cake was dissolved in chloroform, and the precipitate was recrystallized from methanol, followed by filtration and drying to obtain 6.45 g (yield: 71%) of Compound (9) .
(중간체 (10)의 합성)(Synthesis of intermediate 10 )
클로로포름 200 mL에 화합물(9) 6.45 g(15.3 mmol)과 NBS 2.99 g(16.8 mmol)을 넣고 12시간 동안 환류 교반하였다. 반응액을 상온으로 냉각한 후 물 200 mL로 세척하고 무수황산마그네슘으로 건조, 여과하였다. 여과액을 감압 농축한 후 잔류물을 클로로포름으로 녹여 메탄올로 재결정하고 여과, 건조하여 화합물(10) 6.27 g(수율 82%)을 얻었다.
6.45 g (15.3 mmol) of the compound (9) and 2.99 g (16.8 mmol) of NBS were added to 200 mL of chloroform and the mixture was refluxed for 12 hours. The reaction solution was cooled to room temperature, washed with 200 mL of water, dried over anhydrous magnesium sulfate, and filtered. The filtrate was concentrated under reduced pressure, and the residue was dissolved in chloroform, and the residue was recrystallized from methanol, followed by filtration and drying to obtain 6.27 g (yield: 82%) of Compound (10) .
(최종 화합물의 합성)(Synthesis of final compound)
화합물(10) 0.50 g(1.00 mmol)과 4-(9H-카르바졸-9-일)페닐보로닉산피나콜에스테르(4-(9H-carbazol-9-yl)phenylboronic acid pinacol ester) 0.44 g(1.10 mmol)을 톨루엔 5 mL와 에탄올 2 mL에 녹이고 테트라키스트리페닐포스핀팔라듐 0.035 g(0.030 mmol)과 2M 탄산칼륨 수용액 1.5 mL를 가하여 12시간 동안 환류 교반하였다. 반응 혼합물을 상온으로 냉각한 후 생성된 침전을 감압 여과하고 톨루엔, 물, 메탄올로 세척하였다. 여과된 침전을 클로로포름에 녹여 메탄올로 재결정하고 여과, 건조하여 화합물(3-8, mks-3-46) 0.47 g(수율 71%)을 얻었다.Compound (10) 0.50 g (1.00 mmol ) and 4- (9H- carbazole-9-yl) phenyl view it in acid pinacol ester (4- (9H-carbazol-9 -yl) phenylboronic acid pinacol ester) 0.44 g ( 1.10 mmol) was dissolved in toluene (5 mL) and ethanol (2 mL), and 0.035 g (0.030 mmol) of tetrakistriphenylphosphine palladium and 1.5 mL of 2M potassium carbonate aqueous solution were added thereto and stirred under reflux for 12 hours. The reaction mixture was cooled to room temperature and the resulting precipitate was filtered under reduced pressure and washed with toluene, water, and methanol. The filtered precipitate was dissolved in chloroform and recrystallized from methanol, followed by filtration and drying to obtain 0.47 g (yield: 71%) of the compound ( 3-8, mks-3-46 ).
LC-MS: [M+H]+= 662.55(도 9 참조).LC-MS: [M + H] < + > = 662.55 (see Fig. 9).
합성예 9: 화합물 3-9 (msk-3-48)의 합성Synthesis Example 9: Synthesis of Compound 3-9 (msk-3-48)
msk-3-48의 합성 경로를 이하에 나타낸다.The synthesis route of msk-3-48 is shown below.
(최종 화합물의 합성)(Synthesis of final compound)
화합물(10) 0.50 g(1.00 mmol)과 3-(9H-카르바졸-9-일)페닐보로닉산피나콜에스테르(3-(9H-carbazol-9-yl)phenylboronic acid pinacol ester) 0.44 g(1.10 mmol)을 톨루엔 5 mL와 에탄올 2 mL에 녹이고 테트라키스트리페닐포스핀팔라듐 0.035 g(0.030 mmol)과 2M 탄산칼륨 수용액 1.5 mL를 가하여 12시간 동안 환류 교반하였다. 반응 혼합물을 상온으로 냉각한 후 디클로로메탄 70 mL를 가하고, 유기층을 물로 세척하고 감압 농축하였다. 농축 잔류물을 디클로로메탄에 녹여 메탄올로 재결정하고 여과, 건조하여 화합물(3-9, mks-3-48) 0.32 g(수율 48%)을 얻었다.0.44 g (1.00 mmol) of compound (10) and 0.50 g (1.00 mmol) of 3- (9H-carbazol-9-yl) phenylboronic acid pinacol ester 1.10 mmol) was dissolved in toluene (5 mL) and ethanol (2 mL), and 0.035 g (0.030 mmol) of tetrakistriphenylphosphine palladium and 1.5 mL of 2M potassium carbonate aqueous solution were added thereto and stirred under reflux for 12 hours. After the reaction mixture was cooled to room temperature, 70 mL of dichloromethane was added, and the organic layer was washed with water and concentrated under reduced pressure. The concentrated residue was dissolved in dichloromethane, recrystallized from methanol, filtered and dried to obtain 0.32 g (yield: 48%) of the compound ( 3-9, mks-3-48 ).
LC-MS: [M+H]+= 662.55(도 10 참조).
LC-MS: [M + H] < + > = 662.55 (see Fig. 10).
합성예 10: 화합물 3-10 (msk-4-1)의 합성Synthesis Example 10: Synthesis of Compound 3-10 (msk-4-1)
msk-4-1의 합성 경로를 이하에 나타낸다.The synthesis route of msk-4-1 is shown below.
(최종 화합물의 합성)(Synthesis of final compound)
화합물(10) 0.50 g(1.00 mmol)과 4-(5H-피리도[3,2-b]인돌-5-일)페닐보로닉산피나콜에스테르(4-(5H-pyrido[3,2-b]indol-5-yl)phenylboronic acid pinacol ester) 0.41 g(1.10 mmol)을 톨루엔 5 mL와 에탄올 2 mL에 녹이고 테트라키스트리페닐포스핀팔라듐 0.035 g(0.030 mmol)과 2M 탄산칼륨 수용액 1.5 mL를 가하여 12시간 동안 환류 교반하였다. 반응 혼합물을 상온으로 냉각한 후 생성된 침전을 감압 여과하고 톨루엔, 물, 메탄올로 세척하였다. 여과된 침전을 클로로포름 200 mL에 녹이고 클로로포름이 약 20 mL가 남을 때까지 서서히 감압 농축하였다. 생성된 침전을 감압 여과하고 건조하여 화합물(3-10, mks-4-1) 0.34 g(수율 51%)을 얻었다.A solution of 0.50 g (1.00 mmol) of the compound (10) and 4- (5H-pyrido [3,2- b] indol- b] indol-5-yl) phenylboronic acid pinacol ester (0.41 g, 1.10 mmol) was dissolved in 5 mL of toluene and 2 mL of ethanol, 0.035 g (0.030 mmol) of tetrakistriphenylphosphine palladium and 1.5 mL of a 2M potassium carbonate aqueous solution And the mixture was refluxed for 12 hours. The reaction mixture was cooled to room temperature and the resulting precipitate was filtered under reduced pressure and washed with toluene, water, and methanol. The filtered precipitate was dissolved in 200 mL of chloroform and the solution was gradually concentrated under reduced pressure until about 20 mL of chloroform remained. The resulting precipitate was filtered under reduced pressure and dried to obtain 0.34 g (yield: 51%) of the compound ( 3-10, mks-4-1 ).
LC-MS: [M+H]+= 663.55(도 11 참조).LC-MS: [M + H] < + > = 663.55 (see Fig. 11).
합성예 11: 화합물 3-11 (msk-4-3)의 합성Synthesis Example 11: Synthesis of Compound 3-11 (msk-4-3)
msk-4-3의 합성 경로를 이하에 나타낸다.The synthesis route of msk-4-3 is shown below.
화합물(10) 0.50 g(1.00 mmol)과 3-(5H-피리도[3,2-b]인돌-5-일)페닐보로닉산피나콜에스테르(3-(5H-pyrido[3,2-b]indol-5-yl)phenylboronic acid pinacol ester) 0.41 g(1.10 mmol)을 톨루엔 5 mL와 에탄올 2 mL에 녹이고 테트라키스트리페닐포스핀팔라듐 0.035 g(0.030 mmol)과 2M 탄산칼륨 수용액 1.5 mL를 가하여 12시간 동안 환류 교반하였다. 반응 혼합물을 상온으로 냉각한 후 디클로로메탄 50 mL를 가하고, 유기층을 물로 세척하고 감압 농축하였다. 농축 잔류물을 디클로로메탄에 녹여 메탄올로 재결정하고 여과, 건조하여 화합물(3-11, mks-4-3) 0.44 g(수율 66%)을 얻었다.A solution of 0.50 g (1.00 mmol) of the compound (10) and 3- (5H-pyrido [3,2- b] indol-5-yl) phenylboronic acid pinacol ester b] indol-5-yl) phenylboronic acid pinacol ester (0.41 g, 1.10 mmol) was dissolved in 5 mL of toluene and 2 mL of ethanol, 0.035 g (0.030 mmol) of tetrakistriphenylphosphine palladium and 1.5 mL of a 2M potassium carbonate aqueous solution And the mixture was refluxed for 12 hours. After the reaction mixture was cooled to room temperature, 50 mL of dichloromethane was added thereto, and the organic layer was washed with water and concentrated under reduced pressure. The concentrated residue was dissolved in dichloromethane, recrystallized from methanol, filtered and dried to obtain 0.44 g (yield 66%) of the compound (3-11, mks-4-3) .
LC-MS: [M+H]+= 663.55(최종 화합물의 합성)(도 12 참조).LC-MS: [M + H] < + > = 663.55 (synthesis of final compound) (see Fig. 12).
합성예 12: 화합물 3-12 (msk-4-5)의 합성Synthesis Example 12: Synthesis of Compound 3-12 (msk-4-5)
msk-4-5의 합성 경로를 이하에 나타낸다.The synthesis route of msk-4-5 is shown below.
(최종 화합물의 합성)(Synthesis of final compound)
화합물(10) 0.50 g(1.00 mmol)과 4-(1-페닐-1H-벤지미다졸-2-일)페닐보로닉산피나콜에스테르(4-(1-Phenyl-1H-benzimidazole-2-yl)phenylboronic acid pinacol ester) 0.44 g(1.10 mmol)을 톨루엔 5 mL와 에탄올 2 mL에 녹이고 테트라키스트리페닐포스핀팔라듐 0.035 g(0.030 mmol)과 2M 탄산칼륨 수용액 1.5 mL를 가하여 12시간 동안 환류 교반하였다. 반응 혼합물을 상온으로 냉각한 후 생성된 침전을 감압 여과하고 톨루엔, 물, 메탄올로 세척하였다. 여과된 침전을 클로로포름에 녹여 노말헥산으로 재결정하고 여과, 건조하여 화합물(3-12, mks-4-5) 0.57 g(수율 83%)을 얻었다.0.50 g (1.00 mmol) of the compound (10) and 4- (1-phenyl-1H-benzimidazol-2-yl) phenylboronic acid pinacol ester ) phenylboronic acid pinacol ester (0.44 g, 1.10 mmol) was dissolved in 5 mL of toluene and 2 mL of ethanol, 0.035 g (0.030 mmol) of tetrakistriphenylphosphine palladium and 1.5 mL of 2M potassium carbonate aqueous solution were added thereto and the mixture was refluxed for 12 hours . The reaction mixture was cooled to room temperature and the resulting precipitate was filtered under reduced pressure and washed with toluene, water, and methanol. The filtered precipitate was dissolved in chloroform, recrystallized from n-hexane, filtered, and dried to obtain 0.57 g (yield 83%) of the compound ( 3-12, mks-4-5 ).
LC-MS: [M+H]+=689.63(도 13 참조).
LC-MS: [M + H] < + > = 689.63 (see Fig. 13).
합성예 13: 화합물 3-13 (msk-4-7)의 합성Synthesis Example 13: Synthesis of Compound 3-13 (msk-4-7)
msk-4-7의 합성 경로를 이하에 나타낸다.The synthesis route of msk-4-7 is shown below.
(최종 화합물의 합성)(Synthesis of final compound)
화합물(10) 0.50 g(1.00 mmol)과 (9-페닐-9H-카르바졸-3-일)보로닉산((9-phenyl-9H-carbazol-3-yl)boronic acid) 0.32 g(1.10 mmol)을 톨루엔 5 mL와 에탄올 2 mL에 녹이고 테트라키스트리페닐포스핀팔라듐 0.035 g(0.030 mmol)과 2M 탄산칼륨 수용액 1.5 mL를 가하여 12시간 동안 환류 교반하였다. 반응 혼합물을 상온으로 냉각한 후 디클로로메탄 50 mL를 가하고, 유기층을 물로 세척하고 톨루엔이 약 3 mL 가량 남을 때까지 감압 농축한 후 1시간 동안 상온에서 교반하였다. 생성된 침전을 감압 여과한 후 습체를 컬럼크로마토그래피(에틸아세테이트/노말헥산 1:3 → 1:2)로 주 생성물을 분리하여 화합물(3-13, mks-4-7) 0.30 g(수율 45%)을 얻었다.Compound (10) 0.50 g (1.00 mmol ) and (9-phenyl -9H- carbazole-3-yl) Boro acid ((9-phenyl-9H- carbazol-3-yl) boronic acid) 0.32 g (1.10 mmol) Was dissolved in 5 mL of toluene and 2 mL of ethanol, 0.035 g (0.030 mmol) of tetrakis (triphenylphosphine) palladium and 1.5 mL of 2M potassium carbonate aqueous solution were added, and the mixture was refluxed with stirring for 12 hours. The reaction mixture was cooled to room temperature, and 50 mL of dichloromethane was added thereto. The organic layer was washed with water, concentrated under reduced pressure until about 3 mL of toluene remained, and then stirred at room temperature for 1 hour. The resultant precipitate was filtered under reduced pressure, and the obtained product was separated by column chromatography (ethyl acetate / n-hexane 1: 3 → 1: 2) to obtain 0.30 g of a compound ( 3-13, mks-4-7 ) %).
LC-MS: [M+H]+= 662.55(도 14 참조).
LC-MS: [M + H] < + > = 662.55 (see Fig. 14).
합성예 14: 화합물 3-14 (msk-4-11)의 합성Synthesis Example 14: Synthesis of Compound 3-14 (msk-4-11)
msk-4-11의 합성 경로를 이하에 나타낸다.The synthesis route of msk-4-11 is shown below.
(최종 화합물의 합성)(Synthesis of final compound)
화합물(5) 0.50 g(1.44 mmol)과 5-(4'-브로모비페닐-4-일)-5H-피리도[3,2-b]인돌(5-(4'-bromobiphenyl-4-yl)-5H-pyrido[3,2-b]indole) 0.48 g(1.20 mmol)을 톨루엔 5 mL와 에탄올 2 mL에 녹이고 테트라키스트리페닐포스핀팔라듐 0.042 g(0.036 mmol)과 2M 탄산칼륨 수용액 2 mL를 가하여 12시간 동안 환류 교반하였다. 반응 혼합물을 상온으로 냉각한 후 생성된 침전을 감압 여과하고 톨루엔, 물, 메탄올로 세척하였다. 여과된 침전을 클로로포름 300 mL에 녹이고 클로로포름이 약 10 mL가 남을 때까지 서서히 감압 농축하였다. 생성된 침전을 감압 여과하고 건조하여 화합물(3-14, mks-4-11) 0.63 g(수율 84%)을 얻었다. 5 -yl) -5H-pyrido [3,2-b] indole (5- (4'-bromobiphenyl-4-yl) ) 5H-pyrido [3,2-b] indole) was dissolved in 5 mL of toluene and 2 mL of ethanol and 0.042 g (0.036 mmol) of tetrakistriphenylphosphine palladium and 2 mL of a 2M aqueous potassium carbonate solution And the mixture was refluxed for 12 hours. The reaction mixture was cooled to room temperature and the resulting precipitate was filtered under reduced pressure and washed with toluene, water, and methanol. The filtered precipitate was dissolved in 300 mL of chloroform and the solution was gradually concentrated under reduced pressure until about 10 mL of chloroform remained. The resulting precipitate was filtered under reduced pressure and dried to obtain 0.63 g (yield: 84%) of the compound ( 3-14, mks-4-11 ).
LC-MS: [M+H]+= 623.50(도 15 참조).
LC-MS: [M + H] < + > = 623.50 (see Fig. 15).
합성예 15: 화합물 3-15 (msk-4-15)의 합성Synthesis Example 15: Synthesis of Compound 3-15 (msk-4-15)
msk-4-15의 합성 경로를 이하에 나타낸다.The synthesis route of msk-4-15 is shown below.
(최종 화합물의 합성)(Synthesis of final compound)
화합물(10) 0.50 g(1.00 mmol)과 4'-(5H-피리도[3,2-b]인돌-5-일)비페닐4-일보로닉산피나콜에스테르(4'-(5H-pyrido[3,2-b]indol-5-yl)biphenyl-4-ylboronic acid pinacol ester) 0.54 g(1.10 mmol)을 톨루엔 5 mL와 에탄올 2 mL에 녹이고 테트라키스트리페닐포스핀팔라듐 0.035 g(0.030 mmol)과 2M 탄산칼륨 수용액 1.5 mL를 가하여 4시간 동안 환류 교반하였다. 반응 혼합물을 상온으로 냉각한 후 생성된 침전을 감압 여과하고 톨루엔, 물, 메탄올로 세척하였다. 여과된 침전을 클로로포름 1100 mL에 녹이고 클로로포름이 약 50 mL가 남을 때까지 서서히 감압 농축하였다. 생성된 침전을 감압 여과하고 건조하여 화합물(3-15, mks-4-15) 0.63 g(수율 85%)을 얻었다.Compound (10) 0.50 g (1.00 mmol ) and 4 '- (5H- pyrido [3,2-b] indol-5-yl) biphenyl-4-Daily acid pinacol ester (4' - (5H-pyrido 0.54 g (1.10 mmol) of [3,2-b] indol-5-yl) biphenyl-4-ylboronic acid pinacol ester was dissolved in 5 mL of toluene and 2 mL of ethanol and 0.035 g of tetrakistriphenylphosphine palladium ) And 1.5 mL of 2M potassium carbonate aqueous solution were added thereto, and the mixture was refluxed and stirred for 4 hours. The reaction mixture was cooled to room temperature and the resulting precipitate was filtered under reduced pressure and washed with toluene, water, and methanol. The filtered precipitate was dissolved in 1100 mL of chloroform and the solution was gradually concentrated under reduced pressure until about 50 mL of chloroform remained. The resulting precipitate was filtered under reduced pressure and dried to obtain 0.63 g (yield: 85%) of the compound ( 3-15, mks-4-15 ).
LC-MS: [M+H]+= 739.66(도 16 참조).
LC-MS: [M + H] < + > = 739.66 (see Fig. 16).
합성예 16: 화합물 3-16 (msk-4-17)의 합성Synthesis Example 16: Synthesis of Compound 3-16 (msk-4-17)
msk-4-17의 합성 경로를 이하에 나타낸다.The synthesis route of msk-4-17 is shown below.
(최종 화합물의 합성)(Synthesis of final compound)
화합물(7) 0.50 g(1.30 mmol)과 4'-(5H-피리도[3,2-b]인돌-5-일)비페닐4-일보로닉산피나콜에스테르(4'-(5H-pyrido[3,2-b]indol-5-yl)biphenyl-4-ylboronic acid pinacol ester) 0.71 g(1.43 mmol)을 톨루엔 5 mL와 에탄올 2 mL에 녹이고 테트라키스트리페닐포스핀팔라듐 0.045 g(0.039 mmol)과 2M 탄산칼륨 수용액 2 mL를 가하여 4시간 동안 환류 교반하였다. 반응 혼합물을 상온으로 냉각한 후 생성된 침전을 감압 여과하고 톨루엔, 물, 메탄올로 세척하였다. 여과된 침전을 클로로포름 300 mL에 녹이고 클로로포름이 약 20 mL가 남을 때까지 서서히 감압 농축하였다. 생성된 침전을 감압 여과하고 건조하여 화합물(3-16, mks-4-17) 0.56 g(수율 69%)을 얻었다.A mixture of 0.50 g (1.30 mmol) of the compound (7) and 4'- (5H-pyrido [3,2- b] indol-5-yl) biphenyl 4-ylboronic acid pinacol ester 0.71 g (1.43 mmol) of [3,2-b] indol-5-yl) biphenyl-4-ylboronic acid pinacol ester was dissolved in 5 mL of toluene and 2 mL of ethanol and 0.045 g of tetrakistriphenylphosphine palladium ) And 2 mL of a 2M aqueous potassium carbonate solution were added, and the mixture was refluxed and stirred for 4 hours. The reaction mixture was cooled to room temperature and the resulting precipitate was filtered under reduced pressure and washed with toluene, water, and methanol. The filtered precipitate was dissolved in 300 mL of chloroform and the solution was gradually concentrated under reduced pressure until about 20 mL of chloroform remained. The resulting precipitate was filtered under reduced pressure and dried to obtain 0.56 g (yield 69%) of the compound ( 3-16, mks-4-17 ).
LC-MS: [M+H]+= 623.50(도 17 참조).
LC-MS: [M + H] < + > = 623.50 (see Fig.
합성예 17: 화합물 3-17 (msk-4-19)의 합성Synthesis Example 17: Synthesis of Compound 3-17 (msk-4-19)
msk-4-19의 합성 경로를 이하에 나타낸다.The synthesis route of msk-4-19 is shown below.
(최종 화합물의 합성)(Synthesis of final compound)
화합물(2) 0.40 g(1.20 mmol)과 4'-(5H-피리도[3,2-b]인돌-5-일)비페닐4-일보로닉산피나콜에스테르(4'-(5H-pyrido[3,2-b]indol-5-yl)biphenyl-4-ylboronic acid pinacol ester) 0.64 g(1.44 mmol)을 톨루엔 5 mL와 에탄올 2 mL에 녹이고 테트라키스트리페닐포스핀팔라듐 0.042 g(0.036 mmol)과 2M 탄산칼륨 수용액 2 mL를 가하여 18시간 동안 환류 교반하였다. 반응 혼합물을 상온으로 냉각한 후 생성된 침전을 감압 여과하고 톨루엔, 물, 메탄올로 세척하였다. 여과된 침전을 클로로포름 250 mL로 녹인 후 클로로포름이 약 20 mL가 남을 때까지 서서히 감압 농축하였다. 생성된 침전을 감압 여과하고 건조하여 화합물(3-17, mks-4-19) 0.45 g(수율 66%)을 얻었다.Compound (2) 0.40 g (1.20 mmol ) and 4 '- (5H- pyrido [3,2-b] indol-5-yl) biphenyl-4-Daily acid pinacol ester (4' - (5H-pyrido 0.64 g (1.44 mmol) of [3,2-b] indol-5-yl) biphenyl-4-ylboronic acid pinacol ester was dissolved in 5 mL of toluene and 2 mL of ethanol and 0.042 g of tetrakis triphenylphosphine palladium ) And 2 mL of a 2M aqueous potassium carbonate solution were added, and the mixture was stirred under reflux for 18 hours. The reaction mixture was cooled to room temperature and the resulting precipitate was filtered under reduced pressure and washed with toluene, water, and methanol. The filtered precipitate was dissolved in 250 mL of chloroform, and then the solution was gradually concentrated under reduced pressure until about 20 mL of chloroform remained. The resulting precipitate was filtered under reduced pressure and dried to obtain 0.45 g (yield 66%) of the compound ( 3-17, mks-4-19 ).
LC-MS: [M+H]+= 573.47(도 18 참조).
LC-MS: [M + H] < + > = 573.47 (see Fig. 18).
합성예 18: 화합물 3-18 (msk-4-29)의 합성Synthesis Example 18: Synthesis of Compound 3-18 (msk-4-29)
msk-4-29의 합성 경로를 이하에 나타낸다.The synthesis route of msk-4-29 is shown below.
(중간체 (11)의 합성)(Synthesis of intermediate 11 )
화합물(10) 6.27 g(12.6 mmol)을 무수 테트라하이드로퓨란 140 mL에 녹이고 -78℃로 냉각하였다. 여기에 n-부틸리튬(1.6M 노말헥산용액) 9.5 mL(15.1 mmol)를 서서히 가하여 30분간 교반한 후 트리메틸보레이트 1.83 g(17.6 mmol)을 가하고 일야 교반하였다. 2N 염산용액 16 mL를 가하여 2시간 동안 교반한 후 생성된 침전을 감압 여과하였다. 여과한 침전을 물 30 mL에 부유시키고 테트라하이드로퓨란 60 mL를 가한 후 30분간 슬러리하였다. 침전을 감압 여과하고 건조하여 화합물(11) 3.20 g(수율 55%)을 얻었다.
6.27 g (12.6 mmol) of compound (10) was dissolved in 140 mL of anhydrous tetrahydrofuran and cooled to -78 째 C. 9.5 mL (15.1 mmol) of n-butyllithium (1.6 M normal hexane solution) was slowly added thereto, followed by stirring for 30 minutes. Trimethylborate (1.83 g, 17.6 mmol) was added thereto and stirred overnight. 16 mL of 2N hydrochloric acid solution was added and stirred for 2 hours, and the resulting precipitate was filtered under reduced pressure. The filtered precipitate was suspended in 30 mL of water, 60 mL of tetrahydrofuran was added, and the mixture was slurried for 30 minutes. The precipitate was filtered under reduced pressure and dried to obtain 3.20 g (yield: 55%) of the compound (11) .
(최종 화합물의 합성)(Synthesis of final compound)
화합물(11) 0.50 g(1.08 mmol)과 2-브로모-9,9-디메틸-9H-플루오렌(2-bromo-9,9-dimethyl-9H-fluorene) 0.23 g(0.83 mmol)을 톨루엔 5 mL와 에탄올 2 mL에 녹이고 테트라키스트리페닐포스핀팔라듐 0.029 g(0.025 mmol)과 2M 탄산칼륨 수용액 1 mL를 가하여 12시간 동안 환류 교반하였다. 반응 혼합물을 상온으로 냉각한 후 톨루엔 50 mL를 가하고, 유기층을 물로 세척하고 감압 농축하였다. 농축 잔류물을 디클로로메탄에 녹여 메탄올로 재결정하고 여과한 후 컬럼크로마토그래피(에틸아세테이트/노말헥산 1:3)로 주 생성물을 분리하여 화합물(3-18, mks-4-29) 0.28 g(수율 55%)을 얻었다.0.23 g (0.83 mmol) of 2-bromo-9,9-dimethyl-9H-fluorene and 0.50 g (1.08 mmol) of the compound (11) mL and
LC-MS: [M+H]+= 613.45(도 19 참조).LC-MS: [M + H] < + > = 613.45 (see Fig. 19).
합성예 19: 화합물 3-19 (msk-4-3)의 합성Synthesis Example 19: Synthesis of Compound 3-19 (msk-4-3)
msk-4-3의 합성 경로를 이하에 나타낸다.The synthesis route of msk-4-3 is shown below.
(최종 화합물의 합성)(Synthesis of final compound)
화합물(11)0.50 g(1.08 mmol)과 2-브로모-9,9'-스피로비[플루오렌](2-bromo-9,9'-spirobi[fluorene]) 0.33 g(0.83 mmol)을 톨루엔 5 mL와 에탄올 2 mL에 녹이고 테트라키스트리페닐포스핀팔라듐 0.029 g(0.025 mmol)과 2M 탄산칼륨 수용액 1 mL를 가하여 12시간 동안 환류 교반하였다. 반응 혼합물을 상온으로 냉각한 후 생성된 침전을 감압 여과하고 톨루엔, 물, 메탄올로 세척하였다. 여과된 침전을 디클로로메탄에 녹여 메탄올로 재결정하고 여과한 후 컬럼크로마토그래피(에틸아세테이트/노말헥산 1:3)로 주 생성물을 분리하여 화합물(3-19, mks-4-31) 0.30 g(수율 49%)을 얻었다.0.33 g (0.83 mmol) of the compound (11) ( 0.50 g, 1.08 mmol) and 2-bromo-9,9'-spirobi [fluorene] And 0.029 g (0.025 mmol) of tetrakistriphenylphosphine palladium and 1 mL of a 2M aqueous solution of potassium carbonate were added thereto, followed by stirring under reflux for 12 hours. The reaction mixture was cooled to room temperature and the resulting precipitate was filtered under reduced pressure and washed with toluene, water, and methanol. The filtered precipitate was dissolved in dichloromethane, recrystallized from methanol, filtered, and then the main product was separated by column chromatography (ethyl acetate / normal hexane 1: 3) to obtain 0.30 g of compound ( 3-19, mks-4-31 ) 49%).
LC-MS: [M+H]+= 735.60(도 20 참조).
LC-MS: [M + H] < + > = 735.60 (see Fig.
합성예 20: 화합물 3-20 (msk-4-33)의 합성Synthesis Example 20: Synthesis of Compound 3-20 (msk-4-33)
msk-4-33의 합성 경로를 이하에 나타낸다.The synthesis route of msk-4-33 is shown below.
(최종 화합물의 합성)(Synthesis of final compound)
화합물(11) 0.50 g(1.08 mmol)과 4-브로모-9,9'-스피로비[플루오렌](4-bromo-9,9'-spirobi[fluorene]) 0.35 g(0.98 mmol)을 톨루엔 5 mL와 에탄올 2 mL에 녹이고 테트라키스트리페닐포스핀팔라듐 0.033 g(0.029 mmol)과 2M 탄산칼륨 수용액 1.5 mL를 가하여 6시간 동안 환류 교반하였다. 반응 혼합물을 상온으로 냉각한 후 생성된 침전을 감압 여과하고 톨루엔, 물, 메탄올로 세척하였다. 여과된 침전을 클로로포름에 녹여 메탄올로 재결정하고 여과한 후 컬럼크로마토그래피(에틸아세테이트/노말헥산 1:3)로 주 생성물을 분리하여 화합물(3-20, mks-4-33) 0.26 g(수율 36%)을 얻었다.0.35 g (0.98 mmol) of compound (11) ( 0.50 g, 1.08 mmol) and 4-bromo-9,9'-spirobi [fluorene] And 0.033 g (0.029 mmol) of tetrakistriphenylphosphine palladium and 1.5 mL of a 2M aqueous potassium carbonate solution were added to the solution, followed by stirring under reflux for 6 hours. The reaction mixture was cooled to room temperature and the resulting precipitate was filtered under reduced pressure and washed with toluene, water, and methanol. The filtered precipitate was dissolved in chloroform and recrystallized from methanol. The obtained product was filtered, and the main product was separated by column chromatography (ethyl acetate / normal hexane 1: 3) to obtain 0.26 g of the compound ( 3-20, mks-4-33 ) %).
LC-MS: [M+H]+= 735.60(도 21 참조).
LC-MS: [M + H] < + > = 735.60 (see FIG.
합성예 21: 화합물 3-21 (msk-4-35)의 합성Synthesis Example 21: Synthesis of Compound 3-21 (msk-4-35)
msk-4-35의 합성 경로를 이하에 나타낸다.The synthesis route of msk-4-35 is shown below.
(최종 화합물의 합성)(Synthesis of final compound)
화합물(11) 0.50 g(1.08 mmol)과 2'-브로모스피로[벤조[c]플루오렌-7,9'-플루오렌](2'-bromospiro[benzo[c]fluorene-7,9'-fluorene]) 0.44 g(0.98 mmol)을 톨루엔 5 mL와 에탄올 2 mL에 녹이고 테트라키스트리페닐포스핀팔라듐 0.033 g(0.029 mmol)과 2M 탄산칼륨 수용액 1.5 mL를 가하여 6시간 동안 환류 교반하였다. 반응 혼합물을 상온으로 냉각한 후 톨루엔 50 mL를 가하고, 유기층을 물로 세척하고 감압 농축한 후 컬럼크로마토그래피(에틸아세테이트/노말헥산 1:3)로 주 생성물을 분리하여 화합물(3-21, mks-4-35) 0.30 g(수율 39%)을 얻었다.A solution of 0.50 g (1.08 mmol) of the compound (11) and 2'-bromospiro [benzo [c] fluorene-7,9'- fluorene]) was dissolved in 5 mL of toluene and 2 mL of ethanol, 0.033 g (0.029 mmol) of tetrakistriphenylphosphine palladium and 1.5 mL of 2M potassium carbonate aqueous solution were added thereto, and the mixture was refluxed with stirring for 6 hours. The reaction mixture was cooled to room temperature, toluene was added to 50 mL, and the organic layer was washed with water and then concentrated under reduced pressure which was purified by column chromatography (ethyl acetate / n-hexane 1: 3) to remove the major product of the compound (3-21, mks- 4-35 ) (0.30 g, yield 39%).
LC-MS: [M+H]+= 785.69(도 22 참조).
LC-MS: [M + H] < + > = 785.69 (see Fig. 22).
합성예 22: 화합물 3-22 (msk-4-37)의 합성Synthesis Example 22: Synthesis of Compound 3-22 (msk-4-37)
msk-4-37의 합성 경로를 이하에 나타낸다.The synthesis route of msk-4-37 is shown below.
(최종 화합물의 합성)(Synthesis of final compound)
화합물(11) 0.50 g(1.08 mmol)과 5-브로모스피로[벤조[c]플루오렌-7,9'-플루오렌](5-bromospiro[benzo[c]fluorene-7,9'-fluorene]) 0.44 g(0.98 mmol)을 톨루엔 5 mL와 에탄올 2 mL에 녹이고 테트라키스트리페닐포스핀팔라듐 0.033 g(0.029 mmol)과 2M 탄산칼륨 수용액 1.5 mL를 가하여 18시간 동안 환류 교반하였다. 반응 혼합물을 상온으로 냉각한 후 생성된 침전을 감압 여과하고 톨루엔, 물, 메탄올로 세척하였다. 여과된 침전을 컬럼크로마토그래피(에틸아세테이트/노말헥산 1:5 → 1:3)로 주 생성물을 분리하여 농축한 후 농축 잔류물을 디클로로메탄에 녹여 메탄올로 재결정하고 여과, 건조하여 화합물(3-22, mks-4-37) 0.27 g(수율 35%)을 얻었다.
A solution of 0.50 g (1.08 mmol) of the compound (11) and 5-bromospiro [benzo [c] fluorene-7,9'-fluorene] ) Was dissolved in 5 mL of toluene and 2 mL of ethanol, 0.033 g (0.029 mmol) of tetrakistriphenylphosphine palladium and 1.5 mL of 2 M potassium carbonate aqueous solution were added thereto, and the mixture was refluxed with stirring for 18 hours. The reaction mixture was cooled to room temperature and the resulting precipitate was filtered under reduced pressure and washed with toluene, water, and methanol. The filtered precipitate was separated and concentrated by column chromatography (ethyl acetate / n-hexane 1: 5 → 1: 3), and the concentrated residue was dissolved in dichloromethane, recrystallized from methanol, filtered and dried to obtain 3- 22, mks-4-37 ) (yield 35%).
LC-MS: [M+H]+= 785.76(도 23 참조).
LC-MS: [M + H] < + > = 785.76 (see Fig. 23).
합성예 23: 화합물 3-23 (Synthesis Example 23: Compound 3-23 ( msk-5-6msk-5-6 )의 합성) Synthesis of
msk-5-6의 합성 경로를 이하에 나타낸다.The synthesis route of msk-5-6 is shown below.
(최종 화합물의 합성)(Synthesis of final compound)
화합물(11) 0.50 g(1.08 mmol)과 4-브로모-N,N-디페닐아닐린 0.32 g(0.98 mmol)을 톨루엔 5 mL와 에탄올 2 mL에 녹이고 테트라키스트리페닐포스핀팔라듐 0.033 g(0.029 mmol)과 2M 탄산칼륨 수용액 1.5 mL를 가하여 6시간 동안 환류 교반하였다. 반응 혼합물을 상온으로 냉각한 후 생성된 침전을 감압 여과하고 톨루엔, 물, 메탄올로 세척하였다. 여과된 침전을 컬럼크로마토그래피(에틸아세테이트/노말헥산 1:5 → 1:3)로 주 생성물을 분리하여 농축한 후 농축 잔류물을 디클로로메탄에 녹여 메탄올로 재결정하고 여과, 건조하여 화합물(3-23, mks-6-5) 0.18 g(수율 55%)을 얻었다.0.50 g (1.08 mmol) of the compound (11) and 0.32 g (0.98 mmol) of 4-bromo-N, N-diphenyl aniline were dissolved in 5 mL of toluene and 2 mL of ethanol, 0.033 g of tetrakistriphenylphosphine palladium mmol) and 1.5 mL of a 2M aqueous potassium carbonate solution were added, and the mixture was refluxed with stirring for 6 hours. The reaction mixture was cooled to room temperature and the resulting precipitate was filtered under reduced pressure and washed with toluene, water, and methanol. The filtered precipitate was separated and concentrated by column chromatography (ethyl acetate / n-hexane 1: 5 → 1: 3), and the concentrated residue was dissolved in dichloromethane, recrystallized from methanol, filtered and dried to obtain 3- 23, mks-6-5 ) (yield: 55%).
LC-MS: [M+H]+= 664.55(도 24 참조).
LC-MS: [M + H] < + > = 664.55 (see Fig.
시험예Test Example
본 발명의 OLED 화합물에 대하여 Jasco V-630 기기를 이용하여 UV/VIS 스펙트럼을 측정하고, Jasco FP-8500 기기를 이용하여 PL(photoluminescence) 스펙트럼을 측정하여 하기 표 1에 나타내었다.The UV / VIS spectra of the OLED compounds of the present invention were measured using a Jasco V-630 instrument and PL (photoluminescence) spectra were measured using a Jasco FP-8500 instrument.
(mks-3-8)Compound 3-1
(mks-3-8)
(1.0 x 10-5 M in Methylene Chloride)260, 301, 340, 355, 375, 395
(1.0 x 10 -5 M in Methylene Chloride)
(5.0 x 10-6 M in Methylene Chloride)412.5, 431.5
(5.0 x 10-6 M in Methylene Chloride)
(mks-3-20)Compound 3-2
(mks-3-20)
(1.0 x 10-5 M in Methylene Chloride)261, 340, 356, 375, 396
(1.0 x 10 -5 M in Methylene Chloride)
(5.0 x 10-6 M in Methylene Chloride)410, 430.5
(5.0 x 10-6 M in Methylene Chloride)
(mks-3-22)Compound 3-3
(mks-3-22)
(1.0 x 10-5 M in Methylene Chloride)228, 259, 356, 376, 396
(1.0 x 10 -5 M in Methylene Chloride)
(5.0 x 10-6 M in Methylene Chloride)421, 435
(5.0 x 10-6 M in Methylene Chloride)
(mks-3-34)Compound 3-4
(mks-3-34)
(1.0 x 10-5 M in Methylene Chloride)262, 340, 356, 376, 396
(1.0 x 10 -5 M in Methylene Chloride)
(5.0 x 10-6 M in Methylene Chloride)418.5 431.5
(5.0 x 10-6 M in Methylene Chloride)
(mks-3-36)Compound 3-5
(mks-3-36)
(1.0 x 10-5 M in Methylene Chloride)260, 357, 377, 397,
(1.0 x 10 -5 M in Methylene Chloride)
(5.0 x 10-6 M in Methylene Chloride)426.5
(5.0 x 10-6 M in Methylene Chloride)
(mks-3-38)Compound 3-6
(mks-3-38)
(1.0 x 10-5 M in Methylene Chloride)261, 301, 356, 376, 396
(1.0 x 10 -5 M in Methylene Chloride)
(5.0 x 10-6 M in Methylene Chloride)419, 431
(5.0 x 10-6 M in Methylene Chloride)
(mks-3-40)Compound 3-7
(mks-3-40)
(1.0 x 10-5 M in Methylene Chloride)261, 357, 376, 397
(1.0 x 10 -5 M in Methylene Chloride)
(5.0 x 10-6 M in Methylene Chloride)429
(5.0 x 10-6 M in Methylene Chloride)
(mks-3-46)Compound 3-8
(mks-3-46)
(1.0 x 10-5 M in Methylene Chloride)244, 261, 293, 341, 356, 376, 396
(1.0 x 10 -5 M in Methylene Chloride)
(5.0 x 10-6 M in Methylene Chloride)428.5
(5.0 x 10-6 M in Methylene Chloride)
(mks-3-48)Compound 3-9
(mks-3-48)
(1.0 x 10-5 M in Methylene Chloride)244, 260, 292, 341, 356, 376, 396
(1.0 x 10 -5 M in Methylene Chloride)
(5.0 x 10-6 M in Methylene Chloride)421
(5.0 x 10-6 M in Methylene Chloride)
(mks-4-1)Compound 3-10
(mks-4-1)
(1.0 x 10-5 M in Methylene Chloride)261, 301, 355, 376, 396
(1.0 x 10 -5 M in Methylene Chloride)
(5.0 x 10-6 M in Methylene Chloride)426
(5.0 x 10-6 M in Methylene Chloride)
(mks-4-3)Compound 3-11
(mks-4-3)
(1.0 x 10-5 M in Methylene Chloride)260, 301, 340, 354, 376, 396
(1.0 x 10 -5 M in Methylene Chloride)
(5.0 x 10-6 M in Methylene Chloride)421.5
(5.0 x 10-6 M in Methylene Chloride)
(mks-4-5)Compounds 3-12
(mks-4-5)
(1.0 x 10-5 M in Methylene Chloride)262, 301, 357, 377, 397
(1.0 x 10 -5 M in Methylene Chloride)
(5.0 x 10-6 M in Methylene Chloride)432.5
(5.0 x 10-6 M in Methylene Chloride)
(mks-4-7)Compound 3-13
(mks-4-7)
(1.0 x 10-5 M in Methylene Chloride)251, 259, 290, 350, 378, 397
(1.0 x 10 -5 M in Methylene Chloride)
(5.0 x 10-6 M in Methylene Chloride)442.5
(5.0 x 10-6 M in Methylene Chloride)
(mks-4-11)Compound 3-14
(mks-4-11)
(1.0 x 10-5 M in Methylene Chloride)262, 301, 340, 357, 376, 397
(1.0 x 10 -5 M in Methylene Chloride)
(5.0 x 10-6 M in Methylene Chloride)420.5
(5.0 x 10-6 M in Methylene Chloride)
(mks-4-15)Compound 3-15
(mks-4-15)
(1.0 x 10-5 M in Methylene Chloride)261, 302, 339, 355, 377, 397
(1.0 x 10 -5 M in Methylene Chloride)
(5.0 x 10-6 M in Methylene Chloride)428.5
(5.0 x 10-6 M in Methylene Chloride)
(mks-4-17)Compound 3-16
(mks-4-17)
(1.0 x 10-5 M in Methylene Chloride)261, 302, 341, 357, 377, 397
(1.0 x 10 -5 M in Methylene Chloride)
(5.0 x 10-6 M in Methylene Chloride)428
(5.0 x 10-6 M in Methylene Chloride)
(mks-4-19)Compound 3-17
(mks-4-19)
(1.0 x 10-5 M in Methylene Chloride)262, 301, 340, 356, 376, 396
(1.0 x 10 -5 M in Methylene Chloride)
(5.0 x 10-6 M in Methylene Chloride)422
(5.0 x 10-6 M in Methylene Chloride)
(mks-4-29)Compound 3-18
(mks-4-29)
(1.0 x 10-5 M in Methylene Chloride)262, 303, 358, 377, 397
(1.0 x 10 -5 M in Methylene Chloride)
(5.0 x 10-6 M in Methylene Chloride)431
(5.0 x 10-6 M in Methylene Chloride)
(mks-4-31)Compound 3-19
(mks-4-31)
(1.0 x 10-5 M in Methylene Chloride)260, 300, 358, 378, 398
(1.0 x 10 -5 M in Methylene Chloride)
(5.0 x 10-6 M in Methylene Chloride)431
(5.0 x 10-6 M in Methylene Chloride)
(mks-4-33)Compound 3-20
(mks-4-33)
(1.0 x 10-5 M in Methylene Chloride)259, 298, 357, 377, 397
(1.0 x 10 -5 M in Methylene Chloride)
(5.0 x 10-6 M in Methylene Chloride)422
(5.0 x 10-6 M in Methylene Chloride)
(mks-4-35)Compound 3-21
(mks-4-35)
(1.0 x 10-5 M in Methylene Chloride)241, 254, 301, 343, 357, 378, 398
(1.0 x 10 -5 M in Methylene Chloride)
(5.0 x 10-6 M in Methylene Chloride)432.5
(5.0 x 10-6 M in Methylene Chloride)
(mks-4-37)Compound 3-22
(mks-4-37)
(1.0 x 10-5 M in Methylene Chloride)256, 301, 324, 355, 378, 398
(1.0 x 10 -5 M in Methylene Chloride)
(5.0 x 10-6 M in Methylene Chloride)434
(5.0 x 10-6 M in Methylene Chloride)
(mks-6-5)Compound 3-23
(mks-6-5)
(1.0 x 10-5 M in Methylene Chloride)260, 302, 356, 378, 397
(1.0 x 10 -5 M in Methylene Chloride)
(5.0 x 10-6 M in Methylene Chloride)503
(5.0 x 10-6 M in Methylene Chloride)
소자 제작 실시예Example of fabricating device
소자 제작을 위해 투명 전극인 ITO는 양극 층으로 사용하였고, 2-TNATA는 정공 주입층, NPB는 정공 수송층, αβ-ADN은 발광층의 호스트, Bphen 은 전자 수송층, Liq는 전자 주입층, Al은 음극으로 사용하였다. 이 화합물들의 구조는 하기의 화학식과 같다.2-TNATA is a hole injection layer, NPB is a hole transport layer, αβ-ADN is a host of a light emitting layer, Bphen is an electron transport layer, Liq is an electron injection layer, Al is a cathode, Respectively. The structures of these compounds are shown below.
투명 전극인 ITO는 양극 층으로 사용하였고, 2-TNATA는 정공 주입층, NPB는 정공 수송층, αβ-ADN은 발광층의 호스트, Bphen 은 전자 수송층, Liq는 전자 주입층, Al은 음극으로 사용하였다.
ITO as a transparent electrode was used as an anode layer, 2-TNATA used as a hole injecting layer, NPB used as a hole transporting layer, αβ-ADN used as a host of a light emitting layer, Bphen used an electron transporting layer, Liq used an electron injecting layer and Al used a negative electrode.
비교예 1 : ITO / 2-TNATA / NPB / αβ-AND, mks-2-45 / Bphen / Liq / AlCOMPARATIVE EXAMPLE 1 ITO / 2-TNATA / NPB / αβ-AND, mks-2-45 / Bphen / Liq / Al
청색 형광 유기발광소자는 ITO(180 nm) / 2-TNATA (60 nm) / NPB (20 nm) / αβ-ADN:청색 형광 도판트 10% (30 nm) / Bphen (40 nm) / Liq (2 nm) / Al (100 nm) 순으로 증착하여 소자를 제작하였다. 유기물을 증착하기 전에 ITO 전극은 2 x 10-2 Torr에서 125 W로 2분간 산소 플라즈마 처리를 하였다. 유기물은 9 x 10-7 Torr의 진공도에서 증착하였으며 Liq는 0.1 Å/sec, αβ-ADN은 0.18 Å/sec의 기준으로 청색 형광 도판트는 0.02 Å/sec으로 동시 증착하였고, 나머지 유기물들은 모두 1 Å/sec의 속도로 증착하였다. 실험에 사용 된 청색 형광 도판트 물질은 하기 화학식으로 나타낸 mks-2-45 이며, 도판트의 농도는 10%로 고정하였다. 소자 제작이 끝난 후 소자의 공기 및 수분의 접촉을 막기 위하여 질소 기체로 채워져 있는 글로브박스 안에서 봉지를 하였다. 3M사의 접착용 테이프로 격벽을 형성 후 수분 등을 제거할 수 있는 흡습제인 Barium Oxide를 넣고 유리판을 붙였다. The blue fluorescent organic light-emitting device is composed of ITO (180 nm) / 2-TNATA (60 nm) / NPB (20 nm) / αβ-ADN: blue
상기에서 제조된 유기 발광 소자에 대한 전기적 발광특성을 표 2에 나타내었다.
Table 2 shows the electroluminescent characteristics of the organic light-emitting device prepared above.
실시예 1 : ITO / 2-TNATA / NPB / αβ-AND, 3-2 / Bphen / Liq / AlExample 1: ITO / 2-TNATA / NPB / αβ-AND, 3-2 / Bphen / Liq / Al
상기 비교예 1에서, mks-2-45를 이용하는 대신 상기 합성예 2에서 제조한 3-2(mks-3-20) 화합물을 발광층으로 이용한 것을 제외하고는 상기 비교예 1과 동일한 방법으로 소자를 제작하였다.
In the same manner as in Comparative Example 1 except that mks-2-45 was used in the above Comparative Example 1, the 3-2 (mks-3-20) compound prepared in the above Synthesis Example 2 was used as the light emitting layer. Respectively.
상기에서 제조된 유기 발광 소자에 대한 전기적 발광특성을 표 2 에 나타내었다.
Table 2 shows the electroluminescent characteristics of the organic light-emitting device prepared above.
실시예 2 : ITO / 2-TNATA / NPB / αβ-AND, 3-4 / Bphen / Liq / AlExample 2: ITO / 2-TNATA / NPB / αβ-AND, 3-4 / Bphen / Liq / Al
상기 비교예 1에서, mks-2-45를 이용하는 대신 상기 합성예 2에서 제조한 3-4(mks-3-34) 화합물을 발광층으로 이용한 것을 제외하고는 상기 비교예 1과 동일한 방법으로 소자를 제작하였다.
In the same manner as in Comparative Example 1, except that the compound of 3-4 (mks-3-34) prepared in Synthesis Example 2 was used instead of mks-2-45 in Comparative Example 1, Respectively.
상기에서 제조된 유기 발광 소자에 대한 전기적 발광특성을 표 2 에 나타내었다.
Table 2 shows the electroluminescent characteristics of the organic light-emitting device prepared above.
실시예 3 : ITO / 2-TNATA / NPB / αβ-AND, 3-6 / Bphen / Liq / AlExample 3: ITO / 2-TNATA / NPB / αβ-AND, 3-6 / Bphen / Liq / Al
상기 비교예 1에서, mks-2-45를 이용하는 대신 상기 합성예 2에서 제조한 3-6(mks-3-38) 화합물을 발광층으로 이용한 것을 제외하고는 상기 비교예 1과 동일한 방법으로 소자를 제작하였다.
In the same manner as in Comparative Example 1, except that mks-2-45 was used in the above Comparative Example 1, and the 3-6 (mks-3-38) compound prepared in the above Synthesis Example 2 was used as the light emitting layer, Respectively.
상기에서 제조된 유기 발광 소자에 대한 전기적 발광특성을 표 2에 나타내었다.
Table 2 shows the electroluminescent characteristics of the organic light-emitting device prepared above.
( x , y )Color coordinates
(x, y)
(cd/A)efficiency
(cd / A)
결과result
상기 표 2 및 도 25로 확인할 수 있는 바와 같이 발광층으로 사용하여 소자 제작시 청색 파장 영역에서 발광하며, 비교예 와 실시예 1 ~ 3를 비교 시 색순도와 발광 효율 특성이 향상됨을 확인할 수 있다.
As can be seen from the above Table 2 and FIG. 25, when the device is used as a light emitting layer, the device emits light in the blue wavelength region, and it can be confirmed that the color purity and the light emitting efficiency characteristics are improved when the comparative example and Examples 1 to 3 are compared.
Claims (12)
[화학식 1]
[상기 화학식 1에 있어서,
R1은 수소, C1-C30 알킬, C3-C30 시클로알킬, C6-C30 아릴, C6-C30 아르알킬(aralkyl), C1-C30 헤테로알킬, C2-C30 헤테로시클로알킬, C5-C30 헤테로아릴 및 C5-C30 헤테로아르알킬 중에서 선택되며, 하나의 고리 내에 치환된 둘 이상의 R1은 서로 같거나 다르고, 인접한 R1은 각각 C3-C20 알킬렌이나 C3-C20 알케닐렌으로 서로 연결되어 융합고리를 형성할 수 있고,
p는 1 내지 4의 정수이며,
L1은 독립적으로 화학 결합, C6-C30 아릴 또는 C6-C30 헤테로아릴이며,
L2은 페닐렌이며,
Ar은 ,, 또는 -N(Z1)(Z2)(여기서, R2 및 R3는 각각 독립적으로 상기 R1의 정의와 같고, q 및 r은 각각 독립적으로 1 내지 4의 정수 중에서 선택되며, Z1 및 Z2는 모두 페닐임)이다.]An anthracene derivative represented by the following formula (1).
[Chemical Formula 1]
[In the formula 1,
R 1 is hydrogen, C 1 -C 30 alkyl, C 3 -C 30 cycloalkyl, C 6 -C 30 aryl, C 6 -C 30 aralkyl (aralkyl), C 1 -C 30 heteroalkyl, C 2 -C 30 heterocycloalkyl, C 5 -C 30 heteroaryl and C 5 -C 30 heteroaralkyl is selected from alkyl, substituted with more than one R 1 in one of the rings is the same or different, and adjacent R 1 are each C 3 -C 20 alkylene or C 3 -C 20 alkenylene to form a fused ring,
p is an integer of 1 to 4,
L 1 is independently a chemical bond, C 6 -C 30 aryl or C 6 -C 30 heteroaryl,
L 2 is phenylene,
Ar , , Or -N (Z 1 ) (Z 2 ), wherein R 2 and R 3 are each independently the same as defined for R 1 , q and r are each independently selected from integers from 1 to 4, and Z 1 and Z 2 are both phenyl.]
상기 화학식 1로 표시되는 화합물은 하기 화학식 3에 나열된 구조들 중에서 선택되는 안트라센 유도체.
[화학식 3]
The method according to claim 1,
The compound represented by Formula 1 is an anthracene derivative selected from the structures listed in Formula 3 below.
(3)
상기 안트라센 유도체가 정공주입 재료 또는 정공수송 재료로 사용되는 유기 전계발광 소자.The method according to claim 6,
Wherein the anthracene derivative is used as a hole injecting material or a hole transporting material.
상기 안트라센 유도체가 청색, 녹색, 적색 형광 및 인광 소자의 호스트 재료로 사용되는 유기 전계발광 소자.The method according to claim 6,
Wherein the anthracene derivative is used as a host material of blue, green, red fluorescence and phosphorescent devices.
상기 유기막은 제1 항 또는 제5 항의 안트라센 유도체를 포함하는 유기 전계발광 소자.A first electrode, a second electrode, and at least one organic film disposed between the electrodes,
Wherein the organic layer comprises the anthracene derivative of any one of claims 1 to 5.
상기 유기막은 정공주입층, 정공수송층, 정공주입 기능과 정공수송 기능을 동시에 갖는 기능층, 버퍼층, 전자저지층, 발광층, 정공저지층, 전자수송층, 전자주입층, 및 전자수송 기능과 전자주입 기능을 동시에 갖는 기능층으로 이루어진 군 중에서 선택되는 1층 이상을 포함하는 유기 전계발광 소자.10. The method of claim 9,
The organic layer includes a hole injecting layer, a hole transporting layer, a functional layer having both a hole injecting function and a hole transporting function, a buffer layer, an electron blocking layer, a light emitting layer, a hole blocking layer, an electron transporting layer, And at least one functional layer having at least one functional group at the same time.
상기 안트라센 유도체는 발광층, 양극과 발광층 사이에 배치된 유기막, 및 발광층과 음극 사이에 배치된 유기막으로 이루어진 군 중에서 선택되는 적어도 하나에 포함되는 유기 전계발광 소자.10. The method of claim 9,
Wherein the anthracene derivative is contained in at least one selected from the group consisting of a light emitting layer, an organic layer disposed between the anode and the light emitting layer, and an organic layer disposed between the light emitting layer and the cathode.
상기 안트라센 유도체는 정공주입층, 정공수송층, 및 정공주입 기능과 정공수송 기능을 동시에 갖는 기능층으로 이루어진 군 중에서 선택되는 1층 이상에 포함되는 유기 전계발광 소자.
10. The method of claim 9,
Wherein the anthracene derivative is contained in at least one layer selected from the group consisting of a hole injecting layer, a hole transporting layer, and a functional layer having both a hole injecting function and a hole transporting function.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020130123997A KR101548370B1 (en) | 2013-10-17 | 2013-10-17 | Anthracene derivative and organic electroluminescent device including the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020130123997A KR101548370B1 (en) | 2013-10-17 | 2013-10-17 | Anthracene derivative and organic electroluminescent device including the same |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20150044668A KR20150044668A (en) | 2015-04-27 |
KR101548370B1 true KR101548370B1 (en) | 2015-08-28 |
Family
ID=53036935
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020130123997A KR101548370B1 (en) | 2013-10-17 | 2013-10-17 | Anthracene derivative and organic electroluminescent device including the same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101548370B1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6656800B2 (en) * | 2014-10-22 | 2020-03-04 | 三星ディスプレイ株式會社Samsung Display Co.,Ltd. | Organic electroluminescent element material and organic electroluminescent element using the same |
TWI734694B (en) * | 2015-07-29 | 2021-08-01 | 德商麥克專利有限公司 | Compounds having fluorene structures |
KR102386850B1 (en) * | 2017-08-25 | 2022-04-15 | 삼성디스플레이 주식회사 | Organic electroluminescence device |
CN110845496A (en) * | 2019-11-21 | 2020-02-28 | 吉林奥来德光电材料股份有限公司 | Electron transport material and synthesis method and application thereof |
CN115583941B (en) * | 2022-12-09 | 2023-05-23 | 华南理工大学 | Anthracene-based blue light organic semiconductor material containing triazole, and preparation method and application thereof |
-
2013
- 2013-10-17 KR KR1020130123997A patent/KR101548370B1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
KR20150044668A (en) | 2015-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI464234B (en) | Compound, organic electronic element using the same, and electronic device thereof | |
TWI466978B (en) | Novel organic electroluminescent compounds and organic electroluminescent device using the same | |
JP5797672B2 (en) | Novel organic electroluminescent compound and organic electroluminescent device using the same | |
KR101806464B1 (en) | Pyrimidine derivative substitued with pyridyl group, and organic electroluminescent device including the same | |
TW201105610A (en) | Novel compounds for organic electronic material and organic electronic device using the same | |
TW201035082A (en) | Aromatic amine derivative and organic electroluminescent element | |
KR20100106014A (en) | Novel organic electroluminescent compounds and organic electroluminescent device using the same | |
TW201300499A (en) | Novel organic electroluminescent compound and organic electroluminescent device including the same | |
JP2009514812A (en) | Novel binaphthalene derivative, method for producing the same, and organic electronic device using the same | |
JP2013539205A (en) | Novel organic electroluminescent compound and organic electroluminescent device using the same | |
KR20100119077A (en) | New compounds and organic electronic device using the same | |
KR101813692B1 (en) | pyrimidine derivatives substituted with heteroaryl-substituted phenyl group, and organic electroluminescent device including the same | |
KR101548370B1 (en) | Anthracene derivative and organic electroluminescent device including the same | |
KR20170058619A (en) | Pyrimidine derivative substituted with phenyl group, and organic electroluminescent device including the same | |
KR20110137897A (en) | Fluoranthene derivatives and organic electroluminescent device using the same | |
KR20130123484A (en) | Amine derivative and organic electroluminescent device including the same | |
JP2012525378A (en) | Novel organic electroluminescent compound and organic electroluminescent device using the same | |
KR101785701B1 (en) | pyrimidine derivatives substituted with aryl- or heteroaryl- substituted fluorene group, and organic electroluminescent device including the same | |
KR20160038310A (en) | fused fluoranthene derivatives and organic electroluminescent device including the same | |
KR101661591B1 (en) | triazolyl substituted pyrene derivatives and organic electroluminescent device including the same | |
KR101528767B1 (en) | Antracene derivative and organic electroluminescent device including the same | |
KR101648009B1 (en) | Azafluorene substituted Triazine derivative and organic electroluminescent device including the same | |
KR20170058623A (en) | Pyrimidine derivatives substituted with heteroaryl substituted-pyridyl or -phenyl, and organic electroluminescent device including the same | |
KR101581948B1 (en) | Fluoranthene derivative and organic electroluminescent device including the same | |
KR101714509B1 (en) | Dibenzo-benzimidazol derivatives and organic electroluminescent device including the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20180718 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20190710 Year of fee payment: 5 |